REPORT OF INDEPENDENT
AUDITORS
To the shareholders of
SCITEX CORPORATION LTD.
We have audited the consolidated balance
sheets of Scitex Corporation Ltd. (the Company) and its subsidiaries as of
December 31, 2003 and 2002 and the related consolidated statements of operations,
shareholders equity and cash flows for each of the three years in the period ended
December 31, 2003. These financial statements are the responsibility of the
Companys Board of Directors and management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We did not audit the financial
statements of certain associated companies, the Companys investment in which, as
reflected in the balance sheets as of December 31, 2003 and 2002 is $ 3,328,000 and $
7,247,000, respectively, and the Companys share in losses of which is $ 5,637,000, $
4,106,000 and $ 64,407,000 in 2003, 2002 and 2001, respectively. The financial statements
of those companies were audited by other independent auditors, whose reports have been
furnished to us, and our opinion, insofar as it relates to amounts included for those
companies, is based on the reports of the other independent auditors.
We conducted our audits in accordance
with auditing standards generally accepted in Israel and in the United States, including
those prescribed by the Israeli Auditors (Mode of Performance) Regulations, 1973. Those
standards require that we plan and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures in the
financial statements. An audit also includes assessing the accounting principles used and
significant estimates made by the Companys Board of Directors and management, as
well as evaluating the overall financial statement presentation. We believe that our
audits and the reports of the other independent auditors provide a reasonable basis for
our opinion.
In our opinion, based on our audits
and the reports of the other independent auditors, the consolidated financial statements
referred to above present fairly, in all material respects, the consolidated financial
position of the Company and its subsidiaries as of December 31, 2003 and 2002 and the
consolidated results of operations, shareholders equity and cash flows for each of
the three years in the period ended December 31, 2003, in conformity with accounting
principles generally accepted in the United States.
As discussed in note 2i to the
consolidated financial statements, effective January 1, 2002, the Company changed its
method of accounting for goodwill to conform with FASB statement of Financial Accounting
Standard No. 142 Goodwill and Other intangible assets.
Tel-Aviv, Israel
March 1, 2004
|
|
/s/ Kesselman & Kesselman
Kesselman & Kesselman
Certified Public Accountants (Isr.)
|
SCITEX CORPORATION LTD.
CONSOLIDATED BALANCE
SHEETS
|
December 31
|
|
2003
|
2002
|
|
U.S. dollars in thousands
|
|
|
|
A s s e t s |
|
|
| |
|
| |
|
CURRENT ASSETS: | | |
Cash and cash equivalents | | |
| 52,861 |
|
| 17,814 |
|
Short-term investments | | |
| 8,235 |
|
Restricted deposit | | |
| 18,262 |
|
| 20,203 |
|
Trade receivables | | |
| 36,002 |
|
| 30,555 |
|
Other receivables | | |
| 9,995 |
|
| 7,321 |
|
Inventories (note 14b) | | |
| 22,575 |
|
| 20,060 |
|
Current assets of discontinued operation | | |
| 161,602 |
|
| 135,269 |
|
|
| |
| |
T o t a l current assets | | |
| 309,532 |
|
| 231,222 |
|
|
| |
| |
INVESTMENTS AND OTHER NON-CURRENT | | |
ASSETS: | | |
Associated companies | | |
| 3,328 |
|
| 7,247 |
|
Other investments and non-current assets (note 5) | | |
| 1,301 |
|
| 55,131 |
|
Funds in respect of employee rights upon retirement | | |
| 2,040 |
|
| 1,183 |
|
Deferred income taxes | | |
| 112 |
|
| 1,866 |
|
|
| |
| |
| | |
| 6,781 |
|
| 65,427 |
|
|
| |
| |
PROPERTY, PLANT AND EQUIPMENT, net of | | |
accumulated depreciation and amortization (note 6) | | |
| 9,204 |
|
| 6,074 |
|
|
| |
| |
GOODWILL (note 7) | | |
| 5,472 |
|
| 2,171 |
|
OTHER INTANGIBLE ASSETS, net of accumulated amortization (note 8) | | |
| 18,027 |
|
| 11,367 |
|
NON-CURRENT ASSETS OF DISCONTINUED OPERATION | | |
| 48,897 |
|
| 53,295 |
|
|
| |
| |
| | |
| 397,913 |
|
| 369,556 |
|
|
| |
| |
/s/ Ami Erel
Ami Erel
/s/ Raanan Cohen
Raanan Cohen |
|
)
) Chairman of the Board of Directors
)
) Interim President & Chief Executive Officer |
3
|
December 31
|
|
2003
|
2002
|
|
U.S. dollars in thousands
|
|
|
|
Liabilities and shareholders' equity |
|
|
| |
|
| |
|
CURRENT LIABILITIES: | | |
Short-term bank credit and loans (note 14d) | | |
| 45,351 |
|
| 31,888 |
|
Current maturities of long-term loans (note 14d) | | |
| 2,602 |
|
| 5,248 |
|
Note payable issued to an investee company | | |
| |
|
| 18,523 |
|
Trade payables | | |
| 14,505 |
|
| 14,834 |
|
Taxes on income, net of advances | | |
| 29,517 |
|
| 26,086 |
|
Accrued and other liabilities (note 14c) | | |
| 25,677 |
|
| 16,951 |
|
Current liabilities related to discontinued operation | | |
| 31,935 |
|
| 21,388 |
|
|
| |
| |
T o t a l current liabilities | | |
| 149,587 |
|
| 134,918 |
|
|
| |
| |
LONG-TERM LIABILITIES: | | |
Loans, net of current maturities: (note 14d) | | |
Banks | | |
| 6,623 |
|
| 5,493 |
|
Other | | |
| 3,623 |
|
Liability for employee rights upon retirement (note 9) | | |
| 3,022 |
|
| 1,607 |
|
Long-term liabilities related to discontinued operation | | |
| 5,431 |
|
| 6,359 |
|
|
| |
| |
T o t a l long-term liabilities | | |
| 18,699 |
|
| 13,459 |
|
|
| |
| |
CONVERTIBLE LONG-TERM LOANS FROM | | |
RELATED PARTIES (note 14d) | | |
| 756 |
|
COMMITMENTS AND CONTINGENT LIABILITIES (note 10) | | |
|
| |
| |
T o t a l liabilities | | |
| 169,042 |
|
| 148,377 |
|
|
| |
| |
MINORITY INTEREST | | |
| 4,173 |
|
|
| |
|
SHAREHOLDERS' EQUITY (note 11): | | |
Share capital - ordinary shares of NIS 0.12 par value | | |
(authorized - December 31, 2003 and 2002 - | | |
48,000,000 shares; issued and outstanding - | | |
December 31, 2003 and 2002 - 43,467,388 shares) | | |
| 6,205 |
|
| 6,205 |
|
Capital surplus | | |
| 368,104 |
|
| 364,619 |
|
Accumulated other comprehensive income (loss) | | |
| (552 |
) |
| 801 |
|
Accumulated deficit | | |
| (144,852 |
) |
| (146,239 |
) |
Treasury shares, at cost (December 31, 2003 and 2002 - | | |
448,975 shares) | | |
| (4,207 |
) |
| (4,207 |
) |
|
| |
| |
T o t a l shareholders' equity | | |
| 224,698 |
|
| 221,179 |
|
|
| |
| |
| | |
| 397,913 |
|
| 369,556 |
|
|
| |
| |
The
accompanying notes are an integral part of the financial statements.
4
SCITEX CORPORATION LTD.
CONSOLIDATED STATEMENTS
OF OPERATIONS
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
U.S. dollars in thousands
(except per share data)
|
|
|
|
|
REVENUES: |
|
|
| |
|
| |
|
| |
|
Sales | | |
| 60,653 |
|
| 52,847 |
|
| 59,753 |
|
Services | | |
| 5,638 |
|
| 5,098 |
|
| 4,174 |
|
Supplies | | |
| 36,589 |
|
| 27,716 |
|
| 27,691 |
|
|
| |
| |
| |
T o t a l revenues | | |
| 102,880 |
|
| 85,661 |
|
| 91,618 |
|
COST OF REVENUES: | | |
Cost of sales | | |
| 33,766 |
|
| 25,873 |
|
| 27,268 |
|
Cost of services | | |
| 12,438 |
|
| 11,486 |
|
| 12,414 |
|
Cost of supplies | | |
| 12,138 |
|
| 8,562 |
|
| 8,126 |
|
|
| |
| |
| |
T o t a l cost of revenues | | |
| 58,342 |
|
| 45,921 |
|
| 47,808 |
|
|
| |
| |
| |
GROSS PROFIT | | |
| 44,538 |
|
| 39,740 |
|
| 43,810 |
|
|
| |
| |
| |
RESEARCH AND DEVELOPMENT COSTS - net (note 14f) | | |
| 11,070 |
|
| 7,060 |
|
| 6,083 |
|
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (note 14g) | | |
| 35,339 |
|
| 33,393 |
|
| 37,653 |
|
AMORTIZATION OF INTANGIBLE ASSETS (in 2001 - including | | |
goodwill) | | |
| 5,871 |
|
| 2,944 |
|
| 8,460 |
|
WRITE-DOWN OF GOODWILL AND OTHER INTANGIBLE ASSETS | | |
| 2,967 |
|
| |
|
| 14,986 |
|
RESTRUCTURING CHARGES (note 14h) | | |
| 1,590 |
|
| |
|
| 500 |
|
|
| |
| |
| |
OPERATING LOSS | | |
| (12,299 |
) |
| (3,657 |
) |
| (23,872 |
) |
FINANCIAL EXPENSES - net (note 14i) | | |
| (2,651 |
) |
| (3,139 |
) |
| (2,928 |
) |
WRITE-DOWN OF INVESTMENT IN AN ASSOCIATED COMPANY | | |
| |
|
| |
|
| (149,704 |
) |
OTHER INCOME (LOSS) - net (note 14j) | | |
| 787 |
|
| (26,270 |
) |
| (13,034 |
) |
|
| |
| |
| |
LOSS BEFORE TAXES ON INCOME | | |
| (14,163 |
) |
| (33,066 |
) |
| (189,538 |
) |
TAXES ON INCOME (note 12) | | |
| (2,402 |
) |
| 648 |
|
| (2,957 |
) |
SHARE IN LOSSES OF ASSOCIATED COMPANIES | | |
| (5,637 |
) |
| (4,106 |
) |
| (67,507 |
) |
MINORITY INTERESTS IN LOSSES OF A SUBSIDIARY | | |
| 3,546 |
|
|
| |
| |
| |
NET LOSS FROM CONTINUING OPERATIONS | | |
| (18,656 |
) |
| (36,524 |
) |
| (260,002 |
) |
NET INCOME FROM DISCONTINUED OPERATION | | |
| 20,043 |
|
| 4,494 |
|
| 6,982 |
|
|
| |
| |
| |
NET INCOME (LOSS) | | |
| 1,387 |
|
| (32,030 |
) |
| (253,020 |
) |
|
| |
| |
| |
EARNINGS (LOSS) PER SHARE ("EPS") - BASIC: | | |
Continuing operations | | |
$ | (0.43 |
) |
$ | (0.84 |
) |
$ | (6.04 |
) |
Discontinued operation | | |
$ | 0.46 |
|
$ | 0.10 |
|
$ | 0.16 |
|
|
| |
| |
| |
| | |
$ | 0.03 |
|
$ | (0.74 |
) |
$ | (5.88 |
) |
|
| |
| |
| |
EARNINGS (LOSS) PER SHARE ("EPS") - DILUTED: | | |
Continuing operations | | |
$ | (0.43 |
) |
$ | (0.84 |
) |
$ | (6.04 |
) |
Discontinued operation | | |
$ | 0.46 |
|
$ | 0.10 |
|
$ | 0.16 |
|
|
| |
| |
| |
| | |
$ | 0.03 |
|
$ | (0.74 |
) |
$ | (5.88 |
) |
|
| |
| |
| |
WEIGHTED AVERAGE NUMBER OF SHARES | | |
USED IN COMPUTATION OF EPS (in thousands): | | |
Basic | | |
| 43,018 |
|
| 43,018 |
|
| 43,018 |
|
|
| |
| |
| |
Diluted | | |
| 43,018 |
|
| 43,018 |
|
| 43,018 |
|
|
| |
| |
| |
The
accompanying notes are an integral part of the financial statements.
5
SCITEX CORPORATION LTD.
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY
|
Share
capital
|
Capital
surplus
|
Accumulated
other
comprehensive
Income (loss)
|
Retained
earnings
(accumulated
deficit)
|
Treasury
shares
|
Total
shareholders'
equity
|
|
U.S. dollars in thousands
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE AT JANUARY 1, 2001 |
|
|
| 6,205 |
|
| 364,619 |
|
| 904 |
|
| 138,811 |
|
| (4,207 |
) |
| 506,332 |
|
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2001: | | |
Net loss | | |
| |
|
| |
|
| |
|
| (253,020 |
) |
| |
|
| (253,020 |
) |
Other comprehensive income (loss), net, in respect of: | | |
Currency translation adjustments | | |
| |
|
| |
|
| (306 |
) |
| |
|
| |
|
| (306 |
) |
Available-for-sale securities | | |
| |
|
| |
|
| 7,342 |
|
| |
|
| |
|
| 7,342 |
|
Derivative instruments designated for cash flow hedge | | |
| |
|
| |
|
| (200 |
) |
| |
|
| |
|
| (200 |
) |
|
|
|
|
|
|
| |
Total comprehensive loss | | |
| |
|
| |
|
| |
|
| |
|
| |
|
| (246,184 |
) |
|
|
|
|
|
|
| |
Issuance of shares by a development-stage associated company | | |
| |
|
| |
|
| 14 |
|
| |
|
| |
|
| 14 |
|
|
| |
| |
| |
| |
| |
| |
BALANCE AT DECEMBER 31, 2001 | | |
| 6,205 |
|
| 364,619 |
|
| 7,754 |
|
| (114,209 |
) |
| (4,207 |
) |
| 260,162 |
|
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2002: | | |
Net loss | | |
| |
|
| |
|
| |
|
| (32,030 |
) |
| |
|
| (32,030 |
) |
Other comprehensive income (loss), net, in respect of: | | |
Currency translation adjustments | | |
| |
|
| |
|
| 189 |
|
| |
|
| |
|
| 189 |
|
Available-for-sale securities | | |
| |
|
| |
|
| (7,342 |
) |
| |
|
| |
|
| (7,342 |
) |
Derivative instruments designated for cash flow hedge | | |
| |
|
| |
|
| 200 |
|
| |
|
| |
|
| 200 |
|
|
|
|
|
|
|
| |
Total comprehensive loss | | |
| |
|
| |
|
| |
|
| |
|
| |
|
| (38,983 |
) |
|
| |
| |
| |
| |
| |
| |
BALANCE AT DECEMBER 31, 2002 | | |
| 6,205 |
|
| 364,619 |
|
| 801 |
|
| (146,239 |
) |
| (4,207 |
) |
| 221,179 |
|
|
| |
| |
| |
| |
| |
| |
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2003: | | |
Net income | | |
| |
|
| |
|
| |
|
| 1,387 |
|
| |
|
| 1,387 |
|
Other comprehensive loss, net, in respect of: | | |
Currency translation adjustments | | |
| |
|
| |
|
| (1,353 |
) |
| |
|
| |
|
| (1,353 |
) |
|
|
|
|
|
|
| |
Total comprehensive income | | |
| |
|
| |
|
| |
|
| |
|
| |
|
| 34 |
|
|
|
|
|
|
|
| |
Share in beneficial conversion feature relating to convertible | | |
preferred shares issued by Scitex Vision. See note 3a | | |
| |
|
| 3,485 |
|
| |
|
| |
|
| |
|
| 3,485 |
|
|
| |
| |
| |
| |
| |
| |
BALANCE AT DECEMBER 31, 2003 | | |
| 6,205 |
|
| 368,104 |
|
| (552 |
) |
| (144,852 |
) |
| (4,207 |
) |
| 224,698 |
|
|
| |
| |
| |
| |
| |
| |
The
accompanying notes are an integral part of the financial statements.
6
(Continued 1)
SCITEX CORPORATION LTD.
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
U.S. dollars in thousands
|
|
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
| |
|
| |
|
| |
|
Net income (loss) | | |
| 1,387 |
|
| (32,030 |
) |
| (253,020 |
) |
Net income from discontinued operation | | |
| (20,043 |
) |
| (4,494 |
) |
| (6,982 |
) |
|
| |
| |
| |
Net loss from continuing operations | | |
| (18,656 |
) |
| (36,524 |
) |
| (260,002 |
) |
Adjustments to reconcile net loss from continuing operations | | |
to net cash provided by operating activities: | | |
Income and expenses not involving cash flows: | | |
Minority interests in losses of subsidiaries | | |
| (3,546 |
) |
Share in losses of associated companies - net | | |
| 5,637 |
|
| 4,106 |
|
| 67,506 |
|
Depreciation and amortization | | |
| 9,406 |
|
| 5,194 |
|
| 10,663 |
|
Write-down of goodwill and other intangible assets | | |
| 2,967 |
|
| |
|
| 14,986 |
|
Restructuring charges | | |
| 291 |
|
| |
|
| 500 |
|
Loss (gain) on disposal of fixed assets | | |
| 321 |
|
| (16 |
) |
| 102 |
|
Gain from sale of interest in a subsidiary | | |
| (3,774 |
) |
Share in beneficial conversion feature of convertible | | |
preferred shares issued by a subsidiary | | |
| 3,485 |
|
Loss from change in percentage of holding in an | | |
associated company | | |
| |
|
| |
|
| 4,408 |
|
Gain from sale of available-for-sale securities | | |
| (2,823 |
) |
Loss from sale of investments in an | | |
associated company | | |
| |
|
| |
|
| 6,041 |
|
Write-off and write-down of investments in | | |
investee companies and available-for-sale securities | | |
| 2,493 |
|
| 26,122 |
|
| 5,477 |
|
Write-down of investment in an associated company | | |
| |
|
| |
|
| 149,704 |
|
Interest on long-term note payable | | |
| 236 |
|
| 944 |
|
| 944 |
|
Interest on long-term loans - net | | |
| (603 |
) |
Revaluation of long-term loan | | |
| (408 |
) |
Interest on convertible long-term loans from related parties | | |
| 20 |
|
Deferred income taxes - net | | |
| 1,754 |
|
| (64 |
) |
| (1,802 |
) |
Decrease (increase) in short-term investments | | |
| (8,235 |
) |
| |
|
| 9,511 |
|
Changes in operating asset and liability items: | | |
Increase in accounts receivable | | |
| (6,496 |
) |
| (5,244 |
) |
| (1,356 |
) |
Decrease (increase) in inventories | | |
| 112 |
|
| 1,937 |
|
| (5,093 |
) |
Increase (decrease) in accounts payable and accruals | | |
| 4,248 |
|
| (1,394 |
) |
| (46,783 |
) |
Other items - net | | |
| (8 |
) |
| (254 |
) |
| (248 |
) |
|
| |
| |
| |
Net cash used in continuing operations | | |
| (13,579 |
) |
| (5,193 |
) |
| (45,442 |
) |
Net cash provided by discontinued operation | | |
| 7,415 |
|
| 9,564 |
|
| 22,289 |
|
|
| |
| |
| |
Net cash provided by (used in) operating activities | | |
| (6,164 |
) |
| 4,371 |
|
| (23,153 |
) |
|
| |
| |
| |
CASH FLOWS FROM INVESTING ACTIVITIES: | | |
Acquisition of assets and operations consolidated | | |
for the first time * | | |
| 771 |
|
| (2,181 |
) |
| (2,860 |
) |
Purchase of fixed assets | | |
| (3,306 |
) |
| (10,324 |
) |
| (15,469 |
) |
Proceeds from sale of fixed assets | | |
| |
|
| 10 |
|
| 3,490 |
|
Proceeds from sale of investment in an associated company | | |
| |
|
| |
|
| 76,071 |
|
Proceeds from sale of other investment | | |
| 53,886 |
|
Purchase of intangible assets | | |
| (820 |
) |
| (1,012 |
) |
| (5,123 |
) |
Restricted deposits | | |
| 3,427 |
|
| (20,203 |
) |
Investment in associated companies and other investments | | |
| (3,061 |
) |
| (3,466 |
) |
| (6,138 |
) |
|
| |
| |
| |
Net cash provided by (used in) investing activities | | |
| 50,897 |
|
| (37,176 |
) |
| 49,971 |
|
|
| |
| |
| |
Subtotal - forward | | |
| 44,733 |
|
| (32,805 |
) |
| 26,818 |
|
|
| |
| |
| |
7
(Concluded 2)
SCITEX CORPORATION LTD.
CONSOLIDATED STATEMENTS
OF CASH FLOWS
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
U.S. dollars in thousands
|
|
|
|
|
Subtotal - brought forward |
|
|
| 44,733 |
|
| (32,805 |
) |
| 26,818 |
|
|
| |
| |
| |
CASH FLOWS FROM FINANCING ACTIVITIES: | | |
Increase in long-term liabilities | | |
| 612 |
|
| 8,000 |
|
| 5,500 |
|
Receipt of Convertible long-term loans from related parties | | |
| 933 |
|
Discharge of long-term liabilities | | |
| (666 |
) |
| (8,759 |
) |
| (2,000 |
) |
Repayment of long-term note payable | | |
| (18,759 |
) |
Increase in short-term bank credit - net | | |
| 8,194 |
|
| 5,287 |
|
| 6,341 |
|
|
| |
| |
| |
Net cash provided by (used in) financing activities | | |
| (9,686 |
) |
| 4,528 |
|
| 9,841 |
|
|
| |
| |
| |
NET INCREASE (DECREASE) IN CASH AND CASH | | |
EQUIVALENTS | | |
| 35,047 |
|
| (28,277 |
) |
| 36,659 |
|
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR | | |
| 17,814 |
|
| 46,091 |
|
| 9,432 |
|
|
| |
| |
| |
CASH AND CASH EQUIVALENTS AT END OF YEAR | | |
| 52,861 |
|
| 17,814 |
|
| 46,091 |
|
|
| |
| |
| |
* Acquisition of assets and operations consolidated | | |
for the first time: | | |
Assets and liabilities at the date of acquisition: | | |
Deficiency in working capital (excluding cash | | |
and cash equivalents) | | |
| 4,754 |
|
| |
|
| (361 |
) |
Fixed assets - net | | |
| (4,447 |
) |
| |
|
| (585 |
) |
Goodwill arising on acquisition | | |
| (2,043 |
) |
Intangible assets arising on acquisition | | |
| (11,376 |
) |
| (2,181 |
) |
| (1,914 |
) |
Long-term loans and other liabilities | | |
| 6,361 |
|
Minority interests in subsidiary at date of | | |
acquisition | | |
| 7,522 |
|
|
| |
| |
| |
Cash received (paid) | | |
| 771 |
|
| (2,181 |
) |
| (2,860 |
) |
|
| |
| |
| |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW | | |
INFORMATION: | | |
Interest paid | | |
| 4,166 |
|
| 1,703 |
|
| 604 |
|
|
| |
| |
| |
Income taxes paid | | |
| 2,652 |
|
| 732 |
|
| 20,016 |
|
|
| |
| |
| |
Supplementary information on
investing activities not involving cash flows as to the additional investment in an
associated company in December 2002, see note 4b.
The
accompanying notes are an integral part of the financial statements.
8
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1 GENERAL:
|
Scitex
Corporation Ltd. (the Company) is an Israeli corporation, which through its
subsidiaries operates in one segment wide format digital printing. The
subsidiaries develop, manufacture and market industrial digital inkjet printing solutions
mainly to the graphic arts, packaging and textile markets as well as related
services and consumable products. As of the end of 2003, the Company (through its
wholly-owned subsidiary) operated also in the high-speed digital printing segment, which
was classified as discontinued operation, see b below. In addition, the Company holds
interest in other companies that develop digital printing solution to industrial
applications. Amounts provided in these notes to the consolidated financial statements
pertain to continuing operations unless otherwise indicates. |
|
b. |
Sale
of the High-Speed Digital Printing segment |
|
On
November 25, 2003, the Company entered into an agreement according to which it will sell
substantially all of the assets, liabilities and operations of its indirect wholly-owned
subsidiary Scitex Digital Printing Inc. (SDP) related to its High-Speed
Digital Printing Business, including most of the distribution channels that served SDP,
to Eastman Kodak Company (Kodak), for $ 250 million in cash. Pursuant to the
agreement, a $25 million was held in escrow. $15 million out of the above escrow amount
was released in February 2004 to SDPs parent company (SDC) account, and
the remaining $10 million will be held for up to two years and will be used for
indemnification liabilities under the agreement. |
|
The
assets, net of liabilities sold are distinguishable as a component of the Company and
classified as Assets or Liabilities of discontinued operation in accordance
with Statement of Financial Accounting Standards No. 144 (SFAS 144), Accounting
for the Impairment on Disposal of Long-Lived Assets of the Financial Accounting
Standards Board of the United States (FASB). Direct costs to transact the
sale were comprised of, but not limited to, broker commissions, legal and title transfer
fees and closing costs, which will be expensed upon the completion of the transaction. |
|
The
closing of the transaction occurred on January 5, 2004. As a result of the transaction,
the Company is expected to record a net gain of approximately $ 60 million,
approximately $ 52 million of which will be included in the statement of operations for
the first quarter of 2004, and approximately $ 8 million of which were recognized in the
fourth quarter of 2003 as a tax benefit related to expected utilization of carryforward
tax losses including capital losses and is recorded under income from discontinued
operation. |
|
Operating
results of SDP have been reported in these financial statements as discontinued
operations in accordance with SFAS 144 and the Company has reclassified the results of
operations, the assets and liabilities of the component to be disposed for the prior
period in accordance with provisions of SFAS 144. |
9
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 1 GENERAL
(continued):
|
1) |
The
assets and liabilities of SDP classified as discontinued operation in the
Consolidated Balance Sheets, are as follows: |
|
December 31
|
|
2003
|
2002
|
|
U.S. dollars in thousands
|
|
|
|
A s s e t s |
|
|
| |
|
| |
|
Current assets: | | |
Cash and Short-term investments | | |
| 16,056 |
|
| 15,717 |
|
Trade and other receivables | | |
| 68,811 |
|
| 67,077 |
|
Inventories | | |
| 40,506 |
|
| 31,501 |
|
Deferred income taxes | | |
| 36,229 |
|
| 20,974 |
|
|
| |
| |
T o t a l current assets | | |
| 161,602 |
|
| 135,269 |
|
|
| |
| |
Investment and other non-current assets | | |
| 2,040 |
|
| 1,585 |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net of accumulated | | |
depreciation and amortization | | |
| 26,223 |
|
| 30,783 |
|
|
|
|
|
|
|
|
|
|
Goodwill | | |
| 19,730 |
|
| 19,730 |
|
Other intangible assets, net of accumulated amortization | | |
| 904 |
|
| 1,197 |
|
|
| |
| |
T o t a l assets | | |
| 210,499 |
|
| 188,564 |
|
|
| |
| |
Liabilities | | |
|
|
|
|
|
|
|
|
|
Current liabilities | | |
| 31,935 |
|
| 21,388 |
|
|
|
|
|
|
|
|
|
|
Long-term liabilities: | | |
Deferred income taxes | | |
| 3,883 |
|
| 5,033 |
|
Other | | |
| 1,548 |
|
| 1,326 |
|
|
| |
| |
T o t a l liabilities | | |
| 37,366 |
|
| 27,747 |
|
|
| |
| |
|
2) |
Revenues
and net income from the discontinued operations of SDP are as follow: |
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
U.S. dollars in thousands
|
|
|
|
|
REVENUES |
|
|
| 170,113 |
|
| 157,111 |
|
| 164,596 |
|
|
|
|
|
|
|
|
|
|
|
|
|
COST OF REVENUES | | |
| 101,721 |
|
| 98,573 |
|
| 99,745 |
|
|
| |
| |
| |
GROSS PROFIT | | |
| 68,392 |
|
| 58,538 |
|
| 64,851 |
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER OPERATION EXPENSES | | |
| 56,300 |
|
| 52,772 |
|
| 57,812 |
|
|
| |
| |
| |
OPERATING INCOME | | |
| 12,092 |
|
| 5,766 |
|
| 7,039 |
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCIAL INCOME - net | | |
| 3,970 |
|
| 1,103 |
|
| 40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER LOSSES - net | | |
| (390 |
) |
| (182 |
) |
|
| |
| |
| |
INCOME BEFORE TAXES ON INCOME | | |
| 15,672 |
|
| 6,687 |
|
| 7,079 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TAXES ON INCOME | | |
| (4,371 |
) |
| 2,193 |
|
| 97 |
|
|
| |
| |
| |
NET INCOME FOR THE YEAR | | |
| 20,043 |
|
| 4,494 |
|
| 6,982 |
|
|
| |
| |
| |
10
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 2
SIGNIFICANT ACCOUNTING POLICIES:
|
The
currency of the primary economic environment in which the operations of the Company and
most of its subsidiaries are conducted is the U.S. dollar (dollar or $);
thus, the dollar is the functional currency of the Company and most of its subsidiaries. |
|
For
the Company and those subsidiaries whose functional currency is the dollar, transactions
and balances denominated in dollars are presented at their original amounts. Balances in
non-dollar currencies are translated into dollars using historical and current exchange
rates for non-monetary and monetary balances, respectively. For non-dollar transactions
reflected in the statements of operations, the exchange rates at transaction dates are
used, except for expenses deriving from non-monetary items, which are translated using
historical exchange rates. The currency transaction gains or losses are carried to
financial income or expenses, as appropriate. |
|
The
financial statements of a subsidiary relating to the discontinued operation, whose
functional currency is its local currency, are translated into dollars in accordance with
the principles set forth in Statement of Financial Accounting Standards (FAS)
No. 52 Foreign Currency Translation. The resulting aggregate translation
adjustments are presented in shareholders equity, under accumulated other
comprehensive income (loss)". |
|
2) |
Use
of estimates in the preparation of financial statements |
|
The
preparation of financial statements in conformity with generally accepted accounting
principles requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at
the dates of the financial statements and the reported amounts of revenues and expenses
during the reporting years. Actual results could differ from those estimates. |
|
The
consolidated financial statements have been prepared in accordance with accounting
principles generally accepted in the United States. |
|
b. |
Principles
of consolidation |
|
The
consolidated financial statements include the accounts of the Company and its
subsidiaries. Intercompany balances and transactions have been eliminated in
consolidation. Unrealized profits from intercompany sales have also been eliminated. |
11
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 2 SIGNIFICANT
ACCOUNTING POLICIES (continued):
|
c. |
Cash
and cash equivalents |
|
The
Company and its subsidiaries consider all highly liquid investments, with an original
maturity of three months or less at time of investment, that are not restricted as to
withdrawal or use, to be cash equivalents. |
|
d. |
Investments
in marketable securities |
|
Trading
securities which are carried at fair market value with unrealized gains and losses, are
included in financial income (expenses) net. Trading securities are
presented in the balance sheet under short-term investments. |
|
Other
marketable securities consist of equity securities classified as available-for-sale securities
and are presented in the balance sheet under other investments and non-current
assets. Available-for-sale securities are carried at fair market value with
unrealized gains and losses, and are reported as a separate item under other
comprehensive income (loss)". Realized gains and losses and declines in value that
are considered as other than temporary in nature on available-for-sale securities are
included under other loss net see also note 5(b). |
|
e. |
Other
non-marketable investments |
|
These
investments are carried at cost, net of write-down for decrease in value, which is not of
a temporary nature. |
|
Inventories
are valued at the lower of cost or market. Cost is determined as follows: |
|
Raw-materials
on the moving average basis. |
|
Finished
products and products in process on basis of production costs:
Raw materials on the moving average basis.
Labor and overhead component actual manufacturing costs. |
|
g. |
Investments
in associated companies |
|
Associated
companies are companies over which significant influence is exercised, but which are not
consolidated subsidiaries, and are accounted for by the equity method, net of write-down
for decrease in value, which is not of a temporary nature. The excess of cost of
investment in associated companies over the Companys share in their net assets at
date of acquisition (excess of cost of investment) represents amounts
attributed to know-how and technology. The excess of cost of investment is amortized over
a period of 5 years, commencing in the year of acquisition. |
12
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 2 SIGNIFICANT
ACCOUNTING POLICIES (continued):
|
h. |
Property,
plant and equipment |
|
Property,
plant and equipment are carried at cost and are depreciated by the straight-line method
over their estimated useful life. |
|
Annual
rates of depreciation are as follows: |
|
% |
|
|
|
|
|
|
Machinery and equipment |
10-33 (mainly 20) |
Building |
2.5 |
Office furniture and equipment |
6-33 (mainly 20) |
Motor vehicles |
15-25 (mainly 15) |
|
Leasehold
improvements are amortized by the straight-line method over the term of the lease or the
estimated useful life of the improvements, whichever is shorter. |
|
On
January 1, 2002 the Company adopted FAS No. 142 Goodwill and Other Intangible Assets.
Under FAS 142, goodwill is no longer being amortized but tested for impairment at least
annually. |
|
Prior
to January 1, 2002, goodwill was amortized on a straight-line basis, over periods of 7-15
years. |
|
The
Company identified two reporting units that consisted of its operating segments: wide
format digital printing and high-speed digital printing which was classified as
discontinued operation (see also note 1b). The Company has utilized expected future
discounted cash flows to determine the fair value of the reporting units and whether any
impairment of goodwill existed as of the date of adoption. |
|
The
Company has performed its annual goodwill impairment test during the fourth quarter of
2003. No impairment of goodwill resulted from the annual review performed in 2003. |
|
j. |
Other
intangible assets |
|
Other
intangible assets which consist mainly of technology, are presented at cost and are
amortized by the straight-line method over a period of 5-6 years. These intangible assets
are presented net of write-down in value which is other than temporary, see also note 8. |
13
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 2 SIGNIFICANT
ACCOUNTING POLICIES (continued):
|
k. |
Impairment
in value of long-lived assets |
|
The
company has adopted FAS 144 Accounting for the Impairment or Disposal of Long-Lived
Assets (FAS 144) effective January 1, 2002. FAS 144 requires that
long-lived assets, to be held and used by an entity be reviewed for impairment whenever
events or changes in circumstances indicate that the carrying amount of the assets may
not be recoverable. Under FAS 144, if the sum of the expected future cash flows
(undiscounted and without interest charges) of the long-lived assets is less than the
carrying amount of such assets, an impairment loss would be recognized, and the assets
would be written down to their estimated fair values. |
|
The
adoption of FAS 144 on January 1, 2002 did not have any material impact on
the consolidated financial position and consolidated results of operations of the Company. |
|
l. |
Deferred
income taxes: |
|
1) |
Deferred
taxes are determined utilizing the asset and liability method based on the
estimated future tax effects of differences between the financial accounting
and tax bases of assets and liabilities under the applicable tax laws.
Deferred income tax provisions and benefits are based on the changes in
the deferred tax asset or tax liability from period to period. Valuation
allowances are provided for deferred tax assets when it is more likely
than not that all or a portion of the deferred tax assets will not be
realized. |
|
2) |
The
Company may incur an additional tax liability in the event of an
intercompany dividend distribution by non-Israeli subsidiaries; no
additional tax has been provided, since the Company does not intend to
distribute, in the foreseeable future, dividends which would result in an
additional tax liability. |
|
3) |
Taxes
that would apply in the event of disposal of investments in non-Israeli
subsidiaries have not been taken into account in computing the deferred
taxes as long, as it is the Companys intention to hold these
investments and not to realize them. |
|
4) |
As
stated in note 12a(1)a, upon distribution of dividends from tax-exempt income
of approved enterprises, the amount distributed will be
subject to tax at the rate that would have been applicable had the Company
not been exempted from payment thereof. The Israeli subsidiary intends to
permanently reinvest the amounts of tax-exempt income and does not intend
to cause dividend distribution from such income (see note 12a). Therefore,
no deferred taxes have been provided in respect of such tax-exempt income. |
|
m. |
Comprehensive
income (loss) |
|
In
addition to net loss, other comprehensive income (loss) includes unrealized gains and
losses on available-for-sale securities, currency translation adjustments of non-dollar
currency financial statements of investee companies and gains and losses on certain
derivative instruments designated for cash-flow hedge. |
|
Company
shares held by the Company, are presented as a reduction of shareholders equity, at
their cost to the Company. |
14
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 2 SIGNIFICANT
ACCOUNTING POLICIES (continued):
|
1) |
Revenues
from sales of products and supplies are recognized when an arrangement (usually
in the form of a purchase order) exists, delivery has occurred and title passed
to the customer, the Companys price to the customer is fixed or
determinable and collectability is reasonably assured. With respect to products
with installation requirements, revenue is recognized when all of the above
criteria are met and installation is completed. |
|
Sales
contracts with distributors stipulate fixed prices and current payment terms and are not
subject to the distributors resale or any other contingencies. Accordingly, sales
of finished products to distributors are recognized as revenue upon delivery and after
title passes to distributors. |
|
2) |
Service
revenue is recognized ratably over the contractual period or as services
are performed. |
|
3) |
Warranty
costs are provided for at the same time as the related revenues are
recognized. The annual provision is calculated on the basis of the
expected cost of inputs, based on historical experience. |
|
4) |
Emerging
Issues Task Force (EITF) Issue 00-21, Revenue
Arrangements with Multiple Deliverables addresses the accounting, by
a vendor, for contractual arrangements in which multiple
revenue-generating activities will be performed by the vendor. It is
effective prospectively for all arrangements entered into in fiscal
periods beginning after June 15,2003. EITF Issue 00-21 addresses when and,
if so, how an arrangement involving multiple deliverables should be
divided into separate units of accounting. The Company adopted EITF Issue
00-21 in the year ended December 31, 2003 and it has had no significant
impact on its financial position and results of operations. |
|
p. |
Research
and development costs, net |
|
Research
and development costs are charged to income as incurred. Royalty-bearing grants received
from governments for approved projects are recognized as a reduction of expenses as the
related costs are incurred. |
|
These
costs are charged to income as incurred. |
|
r. |
Shipping
and handling costs |
|
Shipping
and handling costs are classified as a component of marketing expenses. |
|
s. |
Allowance
for doubtful accounts |
|
The
allowance for doubtful accounts is determined as a percentage of specific debts doubtful
of collection. |
15
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 2 SIGNIFICANT
ACCOUNTING POLICIES (continued):
|
t. |
Stock
based compensation |
|
The
Company and its subsidiaries account for employee stock based compensation in accordance
with Accounting Principles Board Opinion No. 25 Accounting for Stock Issued to
Employees (APB 25) and related interpretations. Under APB 25
compensation cost for employee stock option plans is measured using the intrinsic value
based method of accounting, and is amortized by the straight-line method against income,
over the expected service period. |
|
FAS
123 Accounting for Stock-Based Compensation, establishes a fair value based
method accounting for employee stock options or similar equity instruments, and
encouraged adoption of such method for stock compensation plans. However, it also allows
companies to continue to account for those plans the accounting treatment prescribed by
APB 25. |
|
The
following table illustrates the effect on net income (loss) and earning (loss) per share
assuming the Company and its subsidiaries had applied the fair value recognition
provisions of FAS 123 to stock-based employee compensation: |
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
$ in thousands (except for per share data)
|
|
|
|
|
Net loss from continuing operations - as reported |
|
|
| (18,656 |
) |
| (36,524 |
) |
| (260,002 |
) |
Add: stock based employee compensation expenses, | | |
included in reported net loss from continuing | | |
operations | | |
| -,- |
|
| -,- |
|
| -,- |
|
Deduct: stock based employee compensation | | |
expenses determined under fair value method | | |
| (1,018 |
) |
| (2,242 |
) |
| (3,753 |
) |
|
| |
| |
| |
Pro-forma net loss from continuing operations | | |
| (19,674 |
) |
| (38,766 |
) |
| (263,755 |
) |
|
| |
| |
| |
Net income from discontinued operations - as reported | | |
| 20,043 |
|
| 4,494 |
|
| 6,982 |
|
Add: stock based employee compensation expenses, | | |
included in reported net income from discontinued | | |
operations | | |
| -,- |
|
| -,- |
|
| -,- |
|
Deduct: stock based employee compensation | | |
expenses determined under fair value method | | |
| (1,305 |
) |
| (2,109 |
) |
|
| |
| |
| |
Pro-forma net income from discontinued operations | | |
| 18,738 |
|
| 2,385 |
|
| 6,982 |
|
|
| |
| |
| |
Pro-forma net loss | | |
| (936 |
) |
| (36,381 |
) |
| (256,773 |
) |
|
| |
| |
| |
Basic and diluted earning (loss) per share - as reported: | | |
Continuing operations | | |
| (0.43 |
) |
| (0.84 |
) |
| (6.04 |
) |
Discontinuing operations | | |
| 0.46 |
|
| 0.10 |
|
| 0.16 |
|
|
| |
| |
| |
Net income (loss) | | |
| 0.03 |
|
| (0.74 |
) |
| (5.88 |
) |
|
| |
| |
| |
Pro-forma earning (loss) per share : | | |
Continuing operations | | |
| (0.46 |
) |
| (0.90 |
) |
| (6.13 |
) |
Discontinuing operations | | |
| 0.44 |
|
| 0.05 |
|
| 0.16 |
|
|
| |
| |
| |
Net loss | | |
| (0.02 |
) |
| (0.85 |
) |
| (5.97 |
) |
|
| |
| |
| |
16
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 2 SIGNIFICANT
ACCOUNTING POLICIES (continued):
|
u. |
Earnings
(loss) per share (EPS) |
|
Basic
EPS are computed based on the weighted average number of shares outstanding during each
year excluding the treasury stock held by the Company. Diluted EPS reflects the increase
in the weighted average number of shares outstanding that would result from the assumed
exercise of options, calculated using the treasury-stock-method (in 2003, 2002 and 2001)
such effect was not included since it would have been anti-dilutive). In addition,
diluted EPS does not reflect options granted by subsidiaries to be exercised to the
subsidiaries shares and convertible loans, since their effect would have been
anti-dilutive. |
|
v. |
Derivatives
and hedging activities |
|
The
Company has adopted FAS 133 Accounting for derivative instruments and hedging
activities. FAS 133, as amended, establishes accounting and reporting standards for
derivatives and for hedging activities. Under FAS 133, all derivatives are recognized on
the balance sheet at their fair value. On the date that the Company enters into a
derivative contract, it designates the derivative, for accounting purposes, as:
(1) Hedging instrument, or (2) Non-hedging instrument. |
|
For
derivative financial instruments that are designated and qualify as a cash flow hedge,
the effective portions of changes in fair value of the derivative are recorded in other
comprehensive income (loss), and are recognized in the statement of operations when the
hedged item affects earnings. Ineffective portions of changes in the fair value of cash
flow hedges are recognized in earnings. Changes in the fair value of derivatives that do
not qualify for hedge accounting are recognized in earnings. |
|
w. |
First
time application of the equity method in respect of an investment
previously accounted for under the cost method |
|
As
of December 31, 2003, the Company holds approximately 23.47 % of Objet Geometries Ltd. (Objet)
outstanding shares and 23.09 % on a fully diluted basis. Through December 31, 2001, the
Company accounted for this investment under the cost method. Commencing January 2002, the
Company changed its method of accounting for this investment from the
cost method to the equity method as required by APB 18 (The equity method of
accounting for investments in common stock). |
|
The
consolidated financial statements for the year 2001 have been adjusted retroactively to
reflect the adoption of the equity method. |
17
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 2 SIGNIFICANT
ACCOUNTING POLICIES (continued):
|
The
effect of such adjustments on the consolidated statements of operations in the year ended
December 31, 2001 was as follows: |
|
As
previously
reported
|
Effect of
restatement
|
As reported
in these
financial
statements
|
|
$ in thousands
|
|
|
|
|
|
|
|
|
Share in losses of associated companies |
|
|
| (64,763 |
) |
| (2,744 |
) |
| (67,507 |
) |
|
| |
| |
| |
Net loss | | |
| (250,276 |
) |
| (2,744 |
) |
| (253,020 |
) |
|
| |
| |
| |
Loss per share - basic and diluted | | |
$ | (5.82 |
) |
$ | (0.06 |
) |
$ | (5.88 |
) |
|
| |
| |
| |
|
x. |
Recently
issued accounting pronouncements: |
|
1. |
In
January 2003, the FASB issued FASB Interpretation No. 46, Consolidation
of Variable Interest Entities (FIN 46). Under FIN 46, entities are
separated into two populations: (1) those for which voting interests are
used to determine consolidation (this is the most common situation) and
(2) those for which variable interests are used to determine
consolidation. FIN 46 explains how to identify Variable Interest Entities
(VIEs) and how to determine when a business enterprise should include the
assets, liabilities, no controlling interests, and results of activities
of a VIE in its consolidated financial statements. Since issuing FIN 46,
the FASB has proposed various amendments to the Interpretation and has
deferred its effective dates. Most recently, in December 2003, the FASB
issued a revised version of FIN 46 (FIN 46-R), which also provides for a
partial deferral of FIN 46. This partial deferral established the
effective dates for public entities to apply FIN 46 and FIN 46-R based on
the nature of the VIE and the date upon which the public company became
involved with the VIE. In general, the deferral provides that (i) for VIEs
created before February 1, 2003, a public entity must apply FIN 46-R at
the end of the first interim or annual period ending after March 15, 2004,
and may be required to apply FIN 46 at the end of the first interim or
annual period ending after December 15, 2003, if the VIE is a special
purpose entity, and (ii) for VIEs created after January 31, 2003, a public
company must apply FIN 46 at the end of the first interim or annual period
ending after December 15, 2003, as previously required, and then apply FIN
46-R at the end of the first interim or annual reporting period ending
after March 15, 2004. The Company believes that the adoption of FIN 46 and
FIN 46-R will not have material impact on its financial position, results
of operations and cash flows. |
18
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 2 SIGNIFICANT
ACCOUNTING POLICIES (continued):
|
2. |
In
December 2003, the FASB issued SFAS No. 132 (revised 2003), Employers Disclosures
about Pensions and Other Postretirement Benefits, an amendment of FASB
Statements No. 87, 88 and 106, and a revision of FASB Statement No. 132 (FAS
132 (revised 2003)) . This Statement revises employers disclosures
about pension plans and other postretirement benefit plans. It does not
change the measurement or recognition of those plans. The new rules
require additional disclosures about the assets, obligations, cash flows,
and net periodic benefit cost of defined benefit pension plans and other
postretirement benefit plans. Part of the new disclosures provisions are
effective for 2003 calendar year-end financial statements, and accordingly
have been applied by the Company in these consolidated financial
statements. The rest of the provisions of FAS 132, which have a later
effective date, are currently being evaluated by the Company. |
|
Certain
comparative figures have been reclassified to conform to the current year presentation. |
NOTE 3
ACQUISITIONS OF BUSINESSES
|
a. |
Scitex
Vision Ltd. (hereafter Scitex Vision) was formed by the
Company and other investors during 1999 under the name Aprion Digital Ltd.
Upon the formation of Scitex Vision, the Company transferred to Scitex
Vision the activity of its Advanced Printing Products Division, in
consideration for Scitex Vision shares, warrants and convertible note in
the amount of $ 20,000,000. |
|
In
the second quarter of 2001, the Company exercised all of the warrants that were granted
by Scitex Vision, in consideration for $ 2,500,000, and in the third quarter converted
the note into Scitex Vision preferred shares. The excess of cost of investments over the
Companys share in Scitex Visions net assets at dates of transactions, in
total amount of approximately $ 5,000,000, was attributed to technology to be amortized
over five years. |
|
At
December 31, 2002, the Company held approximately 43% of Scitex Visions outstanding
shares and the balance of the investment, accounted for under the equity method, was zero. |
|
On
January 1, 2003, the Company sold all of its shares in its then wholly owned subsidiary
Scitex Vision International Ltd. (then known as Scitex Vision Ltd.) (hereafter
SV international), to Scitex Vision, the Companys then
associated company, in exchange for additional preferred shares in Scitex Vision.
Subsequent to the transaction, the Company holds approximately 75% of Scitex Visions
outstanding shares. The transaction was accounted for, by the Company, as a sale of 25%
in SV international and as acquisition of additional shares in Scitex Vision. The fair
value of the transaction was approximately $ 9 million. As a result, the Company
recognized a net capital gain of $ 289,000 under Other expenses net ($
3,774,000 capital gain resulting from the sale of a portion in SV international, net of $
3,485,000 of dilution loss relating to Scitex Visions preferred shares
anti-dilution mechanism triggered by the transaction). In addition, the Company
recognized a capital surplus of $ 3,485,000 under Beneficial conversion feature
relating to convertible preferred shares issued by Scitex Vision in its
shareholders equity. |
19
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 3
ACQUISITIONS OF BUSINESSES (continued):
|
This
acquisition was accounted for under the purchase method. As a result of the transaction
the Company recorded technology and goodwill of approximately $ 14.8 million and
approximately $ 2 million, respectively, of which approximately $ 3.8 million was
credited to minority interest. The technology is being amortized over 6 years. |
|
Commencing
on January 2003 Scitex Visions financial statements are consolidated with those of
the Company. |
|
Here
after are certain unaudited proforma combined statements of operations data for the year
ended December 31, 2002 as if the acquisition of additional shares in Scitex Vision
occurred on January 1, 2002, after giving effect to purchase accounting adjustments. The
proforma financial information is not necessarily indicative of the combined results that
would have been attained had the acquisition take place at the beginning of 2002, nor is
it necessarily indicative of future results: |
|
Year ended
December 31,
|
|
2002
|
|
(Unaudited)
|
|
U.S. dollars in thousands
(except per share data)
|
Revenues |
|
|
| 91,018 |
|
|
| |
Net loss from continuing operations | | |
| (45,375 |
) |
|
| |
Net loss | | |
| (49,869 |
) |
|
| |
Loss per share for continuing | | |
operation - basic and diluted | | |
$ | (1.05 |
) |
|
| |
Net loss per share - basic and diluted | | |
$ | (1.16 |
) |
|
| |
|
As
to lawsuits filed in connection with this transaction see note 10b(1). |
|
b. |
In
April 2002, SV international acquired some assets and operations from Siantec
SARL (Siantec) and its shareholders in consideration of $
2,470,000, of which $ 1,860,000 was allocated to technology and $ 610,000
to non-compete covenant. Those intangible assets were originally amortized
according to a 6-year amortization rate (as to an impairment of the
acquired intangibles, see note 8). This acquisition was made in order to
obtain the advanced technology in the subsidiarys products. As part
of the transaction additional maximum royalties payment of up to $ 10,000,000
is to be paid conditional upon sales of systems and ink based on Siantecs
technology. The payment of $ 1,000,000 of the total amount is limited to a
5-year period, and the balance of $ 9,000,000 is with no time limitation.
As of December 31, 2003, no additional payment was made due to this
transaction. |
|
c. |
In
March 2001, SV international acquired the ink technology, other assets and
operations from the Techno Ink manufacturing (PTY) Ltd. (Tech Ink)
for an aggregate consideration of $ 2,860,000. The technology is
amortized over 6 years. The agreement provides for additional payments to
Tech Ink of up to a maximum of approximately $ 5,500,000, based on the
achievement of specified financial targets, such as reduction in
manufacturing costs, during the period from 2001 to 2006. As of December
31, 2003, the total amount recorded to goodwill due to this agreement is $
2,441,000, of which $ 1,258,000 was recorded during 2003. |
20
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 4
INVESTMENTS IN ASSOCIATED COMPANIES:
|
a. |
An
investment in Jemtex Ink Jet Ltd. (Jemtex), accounted for by the
equity method, amounted to $ 1,303,000 ($ 2,560,000 including
convertible loan and debentures as described below) and $ 4,703,000 as of
December 31, 2003 and 2002, respectively. In December 2002, the Company signed
a share purchase agreement with Jemtex, according to which, the Company
invested additional $ 2,400,000 in three equal quarterly installments of $
800,000 each. The first installment and an advance of $ 250,000 on the last
payment were made in December 2002. The additional $ 1,350,000 was transferred
in February and May 2003. The excess of cost of investment over the Companys
share in Jemtex net assets at the date of transaction in the amount of $
1,371,000 was attributed to technology to be amortized over five years. |
|
In
addition, Jemtex granted to the Company for no additional consideration, warrants to
purchase (1) 3,181 preferred shares of Jemtex at an exercise price of $ 251.467 per
share, exercisable until January 2, 2004, and (2) 3,181 preferred shares of Jemtex at an
exercise price of $ 251.467 per share exercisable until March 31, 2005. An amount of $
51,000 was allocated to the said warrants out of the total above-mentioned investment of
$ 2,400,000. |
|
In
August 2003, the Company exercised the warrants to purchase 3,181 preferred shares of
Jemtex at an exercise price of $ 251.467 per share, exercisable until January 2, 2004,
and in lieu of 3,181 preferred shares was issued an interest bearing note convertible
(principal and interest) into preferred B shares or a more senior class of shares, as
determined by the Company, in the amount of $ 800,000. |
|
In
November and December 2003, the Company granted to Jemtex advance payments on account of
convertible debentures of $ 100,000 and $ 350,000, respectively. See note 16b. |
|
As
of December 31, 2003, the Companys ownership interest in Jemtex is approximately
49.8 % and approximately 47.8 % on a fully diluted basis. However, commencing
the third quarter of 2003, the Company is the sole financier of Jemtex losses and
accordingly is its full share in Jemtex losses. |
|
b. |
As
to the investment in Objet and its first time application of the equity method,
see note 2w. The balance of this investment as of December 31, 2003 is
approximately $ 767,000, following an additional investment of approximately $
460,000. |
21
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 5 OTHER INVESTMENTS
AND NON-CURRENT ASSETS:
|
December 31,
|
|
2003
|
2002
|
|
$ in thousands
|
|
|
|
Investment in Creo (see b. below) |
|
|
| -,- |
|
| 51,062 |
|
Other investments (see c. below) | | |
| 1,301 |
|
| 3,794 |
|
Non-current assets | | |
| -,- |
|
| 275 |
|
|
| |
| |
| | |
| 1,301 |
|
| 55,131 |
|
|
| |
| |
|
In
June and August 2003, the Company sold all of its remaining holdings in Creo Inc.
(hereafter Creo) shares for a net total consideration of $ 54,000,000
and recorded a gain of approximately $ 3,000,000. The investment in Creo shares was
accounted for as shares available for sale, and following the sale of the shares the
Company realized an amount of approximately $ 750,000 recorded during 2003 to Other
Comprehensive Income in its shareholders equity. Until December 2001 the investment
in Creo was accounted for using the equity method. The Companys share in the losses
of Creo in 2001 amounted to $ 60,183,000. In 2002, due to extended decline in fair market
value, it was determined that the impairment in value of the investment was other than
temporary. Consequently, the accumulated unrealized loss of $ 22,283,000, which was
charged to other loss net in the statement of operation. |
|
c. |
Other
investments represent investments in non-marketable securities in companies
operating in the digital printing and digital imaging industry, in which the
Company does not exercise significant influence, and which are stated at cost,
net of a write-down for decrease in value which is not of a temporary nature,
in the amount of $ 1,301,000. In 2003, due to an extended decline in fair value
of an other than temporary nature, the Company recorded an accumulated loss in
the amount of $ 2,493,000 that was charged to other loss net in
the statement of operations. |
22
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 6 PROPERTY,
PLANT AND EQUIPMENT
|
Grouped
by major classifications, the assets are composed as follows: |
|
December 31
|
|
2003
|
2002
|
|
$ in thousands
|
|
|
|
Machinery and equipment |
|
|
| 4,567 |
|
| 4,027 |
|
Building | | |
| 424 |
|
| 411 |
|
Leasehold improvements | | |
| 4,606 |
|
| 1,854 |
|
Office furniture and equipment | | |
| 5,209 |
|
| 4,750 |
|
Motor vehicles | | |
| 16 |
|
| 34 |
|
|
| |
| |
| | |
| 14,822 |
|
| 11,076 |
|
Less - accumulated depreciation | | |
and amortization | | |
| (5,618 |
) |
| (5,002 |
) |
|
| |
| |
| | |
| 9,204 |
|
| 6,074 |
|
|
| |
| |
|
Depreciation
and amortization of property, plant and equipment from continuing operations totaled $
3,558,000, $ 2,250,000 and $ 2,204,000 in 2003, 2002 and 2001, respectively. |
NOTE 7 GOODWILL
|
a. |
The
changes in the carrying value of goodwill in respect of the continuing
operations for the year ended December 31, 2002 and 2003, are as follows: |
|
$ in
thousands
|
|
|
|
|
|
|
Balance as of January 1, 2002* |
|
|
| 988 |
|
Goodwill acquired during the year | | |
| 1,183 |
|
|
| |
Balance as of December 31, 2002 | | |
| 2,171 |
|
Goodwill acquired during the year | | |
| 3,301 |
|
|
| |
Balance as of December 31, 2003 | | |
| 5,472 |
|
|
| |
|
* |
In
2001 the Company recognized a goodwill impairment charge in the amount of $ 1,925,000,
see also note 8. This impairment was due to an evaluation that was performed by a third
party appraiser, due to the significant decrease in the production of certain products
based on the technology mentioned in note 8. The impairment was made in accordance with
the provisions of FAS No. 121 Accounting for the Impairment of Long-Lived Assets
and for Long-Lived Assets to be Disposed of. |
23
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 7 GOODWILL
(continued):
|
b. |
The
following table illustrates the Companys results adjusted to eliminate
the effect of goodwill amortization expense, including goodwill with
respect of an associated company accounted for by the equity method: |
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
$ in thousands (except for per share data)
|
|
|
|
|
Net loss from continuing operations - as reported |
|
|
| (18,656 |
) |
| (36,524 |
) |
| (260,002 |
) |
Add back: Goodwill amortization related to | | |
continuing operations | | |
| |
|
| |
|
| 708 |
|
Goodwill amortization included in | | |
Share in losses of an associated | | |
Company | | |
| |
|
| |
|
| 23,805 |
|
|
| |
| |
| |
Net loss from continuing operations - adjusted | | |
| (18,656 |
) |
| (36,524 |
) |
| (235,489 |
) |
|
| |
| |
| |
Net income from discontinued operation - as reported | | |
| 20,043 |
|
| 4,494 |
|
| 6,982 |
|
Add back: Goodwill amortization related to | | |
discontinued operation | | |
| |
|
| |
|
| 2,927 |
|
|
| |
| |
| |
Net income from discontinued operation- adjusted | | |
| 20,043 |
|
| 4,494 |
|
| 9,909 |
|
|
| |
| |
| |
Pro-forma net income (loss) | | |
| 1,387 |
|
| (32,030 |
) |
| (225,580 |
) |
|
| |
| |
| |
Basic and diluted loss per share - as reported | | |
Continuing operations | | |
| (0.43 |
) |
| (0.84 |
) |
| (6.04 |
) |
Discontinued operation | | |
| 0.46 |
|
| 0.10 |
|
| 0.16 |
|
|
| |
| |
| |
| | |
| 0.03 |
|
| (0.74 |
) |
| (5.88 |
) |
|
| |
| |
| |
Pro-forma loss per share - adjusted | | |
Continuing operations | | |
| (0.43 |
) |
| (0.84 |
) |
| (5.47 |
) |
Discontinued operation | | |
| 0.46 |
|
| 0.10 |
|
| 0.23 |
|
|
| |
| |
| |
| | |
| 0.03 |
|
| (0.74 |
) |
| (5.24 |
) |
|
| |
| |
| |
NOTE 8 OTHER
INTANGIBLE ASSETS:
|
Composed
as of December 31, 2003 and 2002, as follows: |
|
December 31
|
|
2003
|
2002
|
|
$ in thousands
|
|
|
|
Gross carrying amount: |
|
|
| 48,239 |
|
| 33,049 |
|
Accumulated amortization and impairment: | | |
| (30,212 |
) |
| (21,682 |
) |
|
| |
| |
Amortized balance | | |
| 18,027 |
|
| 11,367 |
|
|
| |
| |
|
*
See note 3a regarding technology acquired during 2003. |
|
Amortization
expense in respect of intangible assets relating to the continuing operation totaled $
5,871,000, $ 2,944,000 and 7,752,000 in 2003, 2002 and 2001, respectively. |
24
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 8 OTHER INTANGIBLE
ASSETS (continued):
|
Estimated
amortization expense for the following years, subsequent to December 31, 2003: |
|
$ in
thousands
|
|
|
|
|
|
|
Year ending December 31: |
|
|
| |
|
2004 | | |
| 5,067 |
|
2005 | | |
| 4,686 |
|
2006 | | |
| 3,747 |
|
2007 | | |
| 2,255 |
|
2008 | | |
| 2,255 |
|
|
In
January 2001, SV international acquired the intellectual property related to the
manufacturing of inks compatible with its machines from Magic Inks B.V. for consideration
of $ 2,887,000. This intangible asset is amortized over 6 years. As to an impairment of
the acquired intangible asset see below. |
|
In
2001 and 2003 the financial statements include a write-down charge due to the impairment
of technology and know-how in a subsidiary, in the amounts of $ 13,061,000 and $
2,967,000, respectively. These impairments followed an evaluation performed by a third
party appraiser, due to the significant decrease in the production of certain products
based on the above-mentioned technologies. The impairment calculation in 2001 and 2003
was prepared in accordance with the provisions of SFAS 121 and SFAS 144, respectively. |
NOTE 9 EMPLOYEE
RIGHTS UPON RETIREMENT:
|
a. |
Israeli
labor laws and agreements require the payment of severance pay upon
dismissal of an employee or upon termination of employment in certain
other circumstances. The liability is based upon the length of service and
the latest monthly salary (one months salary for each year worked),
and is mainly funded with severance pay and pension funds and with
insurance companies (principally with an affiliate of the two major
shareholders of the Company), for which the Company and its Israeli
subsidiaries make monthly payments.
The Company records the long-term obligation as if it was payable at each balance
sheet date on an undiscounted basis. |
|
b. |
The
U.S. subsidiary offers 401(k) matching plans to all eligible employees. |
|
c. |
Substantially
all of the European subsidiaries make contributions to pension plans
administered by insurance companies. |
|
d. |
Severance
pay, pension and defined contribution plan expenses totaled $ 1,523,000, $ 563,000
and $ 476,000 in 2003, 2002 and 2001, respectively. |
|
e. |
The
Company expects to contribute in 2004, $ 626,000 to the insurance companies
and provident fund in respect of its severance pay obligation in Israel. |
25
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 10 COMMITMENTS AND
CONTINGENT LIABILITIES:
|
(a) |
A
subsidiary is committed to pay royalties of 3%-5% to the Government of Israel
on sales of products in the research and development of which the Government
participates by way of grants, up to the amount of the grants received (dollar
linked), plus annual interest based on the Libor, accruing from January 1,
1999. At the time the funding was received, successful development of the
related projects was not assured. In the case of failure of a project that was
partly financed by government grants, the subsidiary is not obligated to pay
any such royalties to the Israeli Government. |
|
At
December 31, 2003, the maximum contingent royalty payable is approximately $ 4.2
million. |
|
Royalties
expense totaled $ 128,000, $ 700,000 and $ 694,000 in 2003, 2002 and 2001, respectively. |
|
(b) |
A
subsidiary is obligated to pay royalties to certain parties, based on
agreements which allow it to use technologies developed by these parties. Such
royalties are based on the revenues from sales of products which incorporate
these technologies or on quantities of such products sold. |
|
Most
of the premises occupied by the Company and its subsidiaries are rented under various
operating lease agreements. Part of the premises in Israel were leased from an affiliate
of the two major shareholders of the Company, see also 3 below. |
|
Minimum
lease payments of the Company and its subsidiaries under the above leases, at rates in
effect on December 31, 2003, are as follows: |
|
$ in thousands
|
|
|
|
|
|
|
Year ending December 31: |
|
|
| |
|
2004 | | |
| 2,005 |
|
2005 | | |
| 1,899 |
|
2006 | | |
| 1,751 |
|
2007 | | |
| 1,711 |
|
2008 | | |
| 1,711 |
|
2009 and thereafter | | |
| 2,317 |
|
|
Most
of the rental payments for the Israeli premises are payable in Israeli currency,
partially linked to the Israeli CPI, to the dollar or both to the dollar and the U.S.
CPI. |
|
Rental
expense relating to continuing operations totaled $ 2,449,000, $ 1,158,000 and $ 1,163,000
in 2003, 2002 and 2001, respectively. |
26
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 10 COMMITMENTS AND
CONTINGENT LIABILITIES (continued):
|
3) |
Commencing
November 1, 2001, the Companys headquarters are located on the
premises of one of its major shareholders. The Company obtains the services of
certain executives and other staff as well as certain services from the
shareholder, for which the Company pays amounts based on formulas determined in
the agreement between the Company and the shareholder. |
|
Expenses
due to the said agreement totaled $ 518,000, $ 445,000 and $ 92,000 in 2003,
2002 and 2001, respectively. |
|
b. |
Contingent
liabilities: |
|
1) |
In
October 2003, a minority shareholder of Scitex Vision filed a NIS 14 million
(approximately $3.1 million) lawsuit against the Company, Scitex
Vision and others, including certain other shareholders of Scitex Vision
(among them, the Companys two main shareholders) and the directors
of Scitex Vision in the period relevant for the lawsuit (three of whom are
present or former office holders of the Company). The lawsuit was brought in
connection with the transaction to combine the operations of SV
international and Scitex Vision that was completed in January 2003. In
particular, the lawsuit alleges that the terms of the transaction and the
manner in which it was effected prejudiced the rights of the plaintiff as
a minority shareholder. At this time, the Company and Scitex Vision are
unable to assess the outcome of this matter, while they intend to defend
it vigorously. No provision was recorded for this matter in these
financial statements. |
|
In
November 2003, the same minority shareholder sent a demand letter to Scitex Vision,
whereby it demanded that Scitex Vision will file a lawsuit against the Company and others
(including Scitex Visions directors), alleging breach of fiduciary duties,
misrepresentations and misleading in connection with the Companys undertaking to
transfer $15 million to SV international as part of the aforesaid transaction. In January
2004, Scitex Vision rejected these demands. In the event that the minority shareholder
decides to commence a derivative action, it is not possible at this stage in time to
predict the outcome of such legal proceedings. No provision was recorded for this matter
in these financial statements. |
|
In
December 2003, the same minority shareholder filed a separate motion against the
Company, Scitex Vision and two other shareholders of Scitex Vision (including one of the
Companys principal shareholders), in connection with a rights offering that was
completed in July 2003. In particular, the motion alleges that the reorganization of
Scitex Visions share capital that was affected in conjunction with the rights
offering was invalid and prejudiced the rights of the minority shareholder. In light of
its arguments, the plaintiff requested the court to order the respondents to provide
information and documents with respect to the reorganization of Scitex Visions
share capital.
At
this stage in time, it is not possible to predict the outcome of this particular matter.
No provision was recorded for this matter in these financial statements. |
27
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
NOTE 10 COMMITMENTS AND
CONTINGENT LIABILITIES (continued):
|
2) |
In
January 2003 a subsidiary has received a letter from the legal advisors of a
service provider claiming compensation in the amount of approximately
$ 845,000. The letter of demand alleges that the subsidiary has a
contractual relationship with this service provider. At this time it is
not possible to assess the outcome of this matter, and the subsidiary
intends to defend it vigorously. No provision was recorded for this matter
in the financial statements. |
|
3) |
In
July 2000 a monetary claim in the amount of approximately $ 413,000 against
the Company was filed with the district court in Jerusalem. In this
lawsuit it was claimed that a machine the Company sold to the plaintiff
did not function as promised by the Company. In April 2000, the Company
sold substantially all of the assets, liabilities and operations related
to its Digital PrePrint business to Creo. Therefore, defense is being
handled by Creo. In the opinion of the Companys management, since
this lawsuit is in the framework of an indemnification agreement with
Creo, it will have minimal effect on the Company, if any. Therefore no
provision was recorded for this matter. |
|
4) |
In
October 2002 the liquidator of a company, which the Company had an investment
in, which was fully written-off during 2001, filed a lawsuit against
directors and other executives of this company. Among the defendants is a
former executive of the Company, for which the Company had directors insurance.
Under the insurance, the maximum amount which the Company might have to
pay is approximately $ 100,000. The Company is vigorously contesting this
lawsuit. Management believes that the chances the Company will have to pay
the said amount are low. Therefore no provision was recorded for this
matter. |
|
6) |
In
December 2003, three minority shareholders of Objet, a company in which
the Company has a 23.47% interest, filed an approximate NIS 7.8 million
(approximately $1.75 million) lawsuit against Objet, certain of its
shareholders, including the Company, and certain of Objets
directors. The lawsuit alleges that the defendants acted in a manner that
prejudiced the rights of the minority shareholders, and breached Objets
obligations to such shareholders. Among the remedies being sought by the
said minority shareholders are compensation, restitution (with linkage and
interest) of the investment amount, or repurchase of the plaintiffs shares
in Objet, and a demand for changes to the terms of certain convertible
loans made to Objet by certain of the defendants including the Company. At
this time the Companys attorneys are still evaluating the claim, and
neither Objet nor the Company is able to give any realistic assessment as
to the outcome of this matter, therefore no provision was recorded. |
|
7) |
In
1997, a lawsuit was filed against the Company in Germany, which suit was also
defended by a third party, claiming $5 million (together with
interest since 1997) in relation to a purported guarantee which would have
required the acquisition by the Company of additional shares in a company
now in liquidation. Following prolonged negotiations, it is probable that
this lawsuit will be settled by both the Company and the third party in
equal shares paying significantly lesser amount than the original claim,
and in respect of which the Company recorded a provision. |
28
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 10 COMMITMENTS AND
CONTINGENT LIABILITIES (continued):
|
8) |
Claims
have been filed against the Company and its subsidiaries in the ordinary
course of business. The Company and its subsidiaries intend to defend
themselves vigorously against those claims. Management does not expect
that the Company will incur substantial expenses in respect thereof;
therefore, no provision has been made for the claims. |
|
9) |
As
to contingent royalties, see note 3a and note 3b. |
|
10) |
As
to tax assessments of two of the Companys subsidiaries, see note 12h. |
|
1) |
In
connection with a bank loan received by SV international, the Company granted
a guarantee in favor of the bank. As of December 31, 2003 the total amount
guaranteed is approximately $ 1,333,000. |
|
2) |
Scitex
Vision granted guarantees in favor of its premises lessor suppliers,
certain of its customers and suppliers and a government institution. As of
December 31, 2003, the guarantees outstanding are as follows: |
|
a. |
Scitex
Vision entered into a surety agreement with a financial institution and
suppliers of its premises lessor, under which the Scitex Vision guarantees
lease payments in favor of the lessor. As of December 31, 2003 the total
amount guaranteed was $ 255,000. The fair value of the guarantee is
immaterial. |
|
b. |
Scitex
Vision entered into a surety agreement with a financial institution and
certain of its suppliers, pursuant to which Scitex Vision guarantees
payments in favor of the suppliers. As of December 31, 2003 the total
amount guaranteed was $ 260,000.The fair value of the guarantee is
immaterial. |
|
c. |
Scitex
Vision has provided guarantees for payment to a governmental institution
in a European country in the total amount of $ 616,000. |
|
d. |
Scitex
Vision entered into a surety agreement with leasing companies and certain
of its customers, under which Scitex Vision guarantees lease payments of
its customers to the leasing companies. As of December 31, 2003 the total
amount guaranteed was $ 175,000. The fair value of the guarantee is
immaterial. |
NOTE 11
SHAREHOLDERS EQUITY:
|
1) |
The
Companys shares are traded on NASDAQ and on the Tel Aviv Stock Exchange (TASE). |
|
On
December 31, 2003 the Companys share closed on NASDAQ and the Tel Aviv Stock
Exchange at approximately $ 5.06 and $ 5.04, respectively. |
|
2) |
The
number of shares stated as issued and outstanding 43,467,388 shares at
December 31, 2003 and 2002 includes 448,975 shares repurchased by
the Company (treasury shares, see note 2n) and held by a trustee for the
benefit of employees within the framework of the Companys share option
plans. These shares, until purchased by employees pursuant to a share option
plan, bear no voting rights or rights to cash dividends. |
29
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 11 SHAREHOLDERS EQUITY
(continued):
|
b. |
Share
incentive and stock option plans: |
|
1) |
On
December 31, 2001, the 2001 annual general meeting of shareholders of
the Company approved the adoption of the Scitex 2001 Stock Option Plan
that permits the grant of options to officers, employees, directors,
consultants and contractors of the Company, its subsidiaries and
controlled entities for the purchase of, initially, up to an aggregate of
750,000 shares of the Company. Option awards may be granted under this
plan until November 5, 2011. The maximum term of an option may not
exceed ten years. Each option can be exercised to purchase one share
having the same rights as the other ordinary shares of the Company. |
|
2) |
On
December 31, 2003, the 2003 annual general meeting of shareholders of
the Company approved the adoption of the Scitex 2003 Share Option Plan
that permits the grant of options to employees, directors, consultants and
contractors of the Company, its subsidiaries and affiliates, under the
provisions of either section 102 or section 3(9) of the Israeli
Income Tax Ordinance. Option awards may be granted under this plan until
November 23, 2013. The maximum term of an option may not exceed ten
years. Each option can be exercised in purchase of one share having the
same rights as the other ordinary shares of the Company. |
|
3) |
The
2003 annual general meeting of shareholders also approved an increase in the
aggregate number of shares that may be issued under the 2001 plan and the
2003 plan to 1,900,000. At December 31, 2003, no options had been
granted under either the 2001 plan or the 2003 plan. |
|
4) |
The
2001 plan replaced two earlier share option plans - the Scitex Israel
Key Employee Share Incentive Plan 1991 (with various sub-plans), mainly
for directors, officers and other key employees of the Company and its
Israeli subsidiaries, and the Scitex International Key Employee Stock
Option Plan 1991 (As Amended, 1995), for officers and other key employees
of non-Israeli subsidiaries. These plans expired in September 2001,
except with respect to outstanding options granted under such plans. The
options granted under such plans generally vested ratably over a period of
3-4 years. The maximum term of an option could not exceed ten years. Each
option can be exercised in purchase of one share having the same rights as
the other ordinary shares. |
|
5) |
The
Israeli option plans are subject to the terms stipulated by Section 102 of
the Israeli Income Tax Ordinance. Inter alia, these terms provide that the
Company will be allowed to claim, as an expense for tax purposes, the
amounts credited to the employees as a benefit in respect of shares or
options granted under the plan, as follows: |
|
Through
December 31, 2002, the amount that the Company was allowed to claim as an expense for tax
purposes will be the amount of the benefit chargeable to tax in the hands of the
employee. As from January 1, 2003, the amount that the Company will be allowed to claim
as an expense for tax purposes, will be the amount of the benefit chargeable to tax as
work income in the hands of the employee, while that part of the benefit that is
chargeable to capital gains tax in the hands of the employee shall not be allowable. All
being subject to the restrictions specified in Section 102 of the Income Tax Ordinance. |
|
The
aforementioned expense will be recognized in the tax year that the benefit is credited to
the employee. |
30
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 11 SHAREHOLDERS EQUITY
(continued):
|
6) |
The
options granted under the Companys plans are exercisable for the purchase
of shares as follows: |
|
December 31
|
|
2003
|
2002
|
|
Number of options
|
|
|
|
At balance sheet date |
|
|
| 978,732 |
|
| 1,139,728 |
|
During the first year thereafter | | |
| 8,334 |
|
| 104,430 |
|
During the second year thereafter | | |
| |
|
| 8,334 |
|
|
| |
| |
| | |
| 987,066 |
|
| 1,252,492 |
|
|
| |
| |
|
7) |
A
summary of the status of the Companys plans at December 31, 2003,
2002 and 2001, and changes during the years ended on those dates, is
presented below: |
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
Number
|
Weighted
average
exercise
price
|
Number
|
Weighted
average
exercise
price
|
Number
|
Weighted
average
exercise
price
|
|
|
$
|
|
$
|
|
$
|
Options outstanding at |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
beginning of year | | |
| 1,252,492 |
|
| 10.34 |
|
| 1,724,203 |
|
| 10.18 |
|
| 2,246,465 |
|
| 10.06 |
|
Changes during the year: | | |
Granted - at fair value | | |
| |
|
| |
|
| |
|
| |
|
| 25,000 |
|
| 8.18 |
|
Forfeited and canceled | | |
| (265,426 |
) |
| 9.82 |
|
| (471,711 |
) |
| 9.76 |
|
| (547,262 |
) |
| 9.59 |
|
|
| |
|
| |
|
| |
|
Options outstanding at end of year | | |
| 987,066 |
|
| 10.48 |
|
| 1,252,492 |
|
| 10.34 |
|
| 1,724,203 |
|
| 10.18 |
|
|
| |
|
| |
|
| |
|
Options exercisable at end of year | | |
| 978,732 |
|
| 10.50 |
|
| 1,139,728 |
|
| 10.33 |
|
| 1,425,617 |
|
| 10.09 |
|
|
| |
|
| |
|
| |
|
Options available for future awards | | |
| 1,900,000 |
|
| |
|
| 750,000 |
|
| |
|
| 750,000 |
|
|
| |
|
| |
|
| |
|
|
The
weighted average fair value of options granted during 2001 is $ 2.76. The fair value
of each option grant is estimated on the date of grant using the Black-Scholes
option-pricing model with the following weighted average assumptions: |
|
Year ended
December 31
|
|
2001
|
|
|
|
|
Dividend yield per share - in dollars |
-,- |
|
|
Expected volatility |
58% |
|
|
Risk-free interest rate |
4.0% |
|
|
Expected life - in years |
2.00 |
|
|
31
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 11 SHAREHOLDERS EQUITY
(continued):
|
8) |
The
following table summarizes information about options under the Companys
plans outstanding at December 31, 2003: |
Options outstanding
|
Options exercisable
|
Range of
exercise prices
|
Number
outstanding at
December 31, 2003
|
Weighted average
remaining
contractual life
|
Weighted
average
exercise
price
|
Number
exercisable at
December 31,
2003
|
Weighted
average
exercise
price
|
$
|
|
Years
|
$
|
|
$
|
|
|
|
|
|
|
8.00 to 8.99 |
|
|
| 25,000 |
|
| 7.0 |
|
| 8.18 |
|
| 16,666 |
|
| 8.18 |
|
9.00 to 9.99 | | |
| 279,999 |
|
| 2.4 |
|
| 9.06 |
|
| 279,999 |
|
| 9.06 |
|
10.00 to 10.99 | | |
| 265,417 |
|
| 6.4 |
|
| 10.68 |
|
| 265,417 |
|
| 10.68 |
|
11.00 to 11.99 | | |
| 370,500 |
|
| 1.5 |
|
| 11.36 |
|
| 370,500 |
|
| 11.36 |
|
12.00 to 12.99 | | |
| 46,150 |
|
| 3.1 |
|
| 12.07 |
|
| 46,150 |
|
| 12.07 |
|
|
| |
|
|
| |
|
8.00 to 12.99 | | |
| 987,066 |
|
| 3.3 |
|
| 10.34 |
|
| 978,732 |
|
| 10.50 |
|
|
| |
|
|
| |
|
|
9) |
An
award in 1999, whereby 50 % of 300,000 options awarded in earlier years to a
related party, with an exercise price of $ 14.75 per option, were
re-priced to an exercise price of $ 11.69 per option (the then market
price per share), accompanied by a waiver of the remaining 50 %. Such
options were exercisable from 1999 and are exercisable until June 2004.
The fair value of each option granted was $ 3.21. In accordance with FIN
44, the re-priced options are accounted for under variable plan
accounting. Under this method of accounting, increases in the fair market
value of the underlying shares result in non-cash compensation charges to
the statement of operations. At December 31, 2003, 2002 and 2001, the
market price of the underlying shares was below $ 11.69 (the exercise
price of the options), thus, no compensation cost has been charged with
respect to these options. Future periods may reflect charges depending on
the fair market price of the underlying shares. |
|
10) |
Stock
option plans of subsidiaries: |
|
a) |
On
February 7, 2000, the Board of Directors of an Israeli subsidiary approved an
employee share option plan (the Subsidiary Plan). Pursuant to the
Subsidiary Plan, 2,600,000 ordinary shares of the subsidiary are reserved for
issuance upon the exercise of 2,600,000 options to be granted to some of the
subsidiarys employees. During 2000, the subsidiary granted 2,254,000
options to employees under the Subsidiary Plan, at an exercise price per share
of $ 6.50. The options vest as follows: 33 % after the first year, another 33 %
after the second year and another 33 % after the third year starting from the
date of beginning of employment of each employee, or the grant date, as
determined by the stock option committee, provided the employee is still in the
subsidiarys employ. Any option not exercised within 7 years of grant date
will expire. During 2001, the subsidiary granted additional 415,000 options
with identical conditions to those granted in 2000, and 258,000 options were
forfeited. During 2002, no options were granted under the Subsidiary Plan. |
|
The
weighted average fair value of options granted by the subsidiary during 2001 is $ 2.44.
The fair value of each option grant is estimated on the date of grant using the
Black-Scholes option-pricing model with the following weighted average assumptions:
dividend yield per share is nil, expected volatility of 50 %, risk-free interest rate of
4.0 %, expected life of 3 years. |
32
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 11 SHAREHOLDERS EQUITY
(continued):
|
None
of these options were exercised and during 2002 all of the outstanding options were
waived by the respective grantees. |
|
In
April 2002 all of this subsidiarys options were canceled. |
|
In
September 2003, the subsidiarys board of directors approved an employee stock
option plan (hereafter the plan), whereunder options to purchase up to 13,179,544
ordinary shares of the subsidiary are to be granted to employees, directors and
consultants of the subsidiary without consideration. Each option can be exercised to
purchase one ordinary share of NIS 0.01 par value of the subsidiary. |
|
Immediately
upon exercise, the ordinary shares purchased in exercise of the option will have the same
rights as of the subsidiarys other ordinary shares. Any option not exercised within
10 years from allotment date will expire, unless extended by the board of directors of
the subsidiary. |
|
At
December 31, 2003, there were 12,531,041 options
outstanding subject to the 2003 plan, of
which
6,079,265 were vested. |
|
All
options were granted at an exercise price of
$ 0.4052, which management determined is not
less than
the fair value of an ordinary share in the date of grant. |
|
The
weighted fair value of options granted by the
subsidiary during 2003 is $ 0.14. The
fair value of each
option grant is estimated on the date of grant using the
Black-Scholes
option-pricing model with the following
weighted average assumptions: dividend yield per
share
is nil, expected volatility of 48%, risk-free interest rate
of 2.2%, expected life
of 3 years. |
|
During
2003, no options were exercised. |
|
In
addition, approximately 193,474 options to purchase ordinary shares of the subsidiary are
held by former directors of the acquired subsidiary. |
|
b) |
In
consideration of a credit line received by an acquired subsidiary a total
amount of 56,180 options were granted to a bank in 2002 and are exercisable in
to ordinary shares of the acquired subsidiary in exercise price set at $8.90
per share. The fair value of the warrant granted to the bank calculated as of
December 31, 2003, was immaterial. |
|
c) |
On
December 6, 2001, the Board of Directors of a United States subsidiary
approved an employee share option plan (the US Subsidiary Plan).
Pursuant to the US Subsidiary Plan, 2,600,000 shares of Common Stock of the
subsidiary are reserved for issuance upon the exercise of 2,600,000 options to
be granted to some of the subsidiarys employees. |
|
During
2001, the subsidiary had granted 957,000 options to employees under the US Subsidiarys
Plan, at an exercise price per share of $ 6.00. During 2002, the subsidiary granted
additional 366,000 options on identical conditions to those grants in 2001, and 66,000
options were forfeited. During 2003, the subsidiary granted additional 143,000 options on
identical conditions to those grants in 2001, and no option were forfeited. The options
vest as follows: 25 % one year from the grant date and thereafter 6.25 % on the last day
of every third calendar month. Any option not exercised within 10 years of grant date
will expire. |
33
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 11 SHAREHOLDERS EQUITY
(continued):
|
The
weighted fair value of options granted by the subsidiary during 2003 is $ 3.99. The
fair value of each option grant is estimated on the date of grant using the Black-Scholes
option-pricing model with the following weighted average assumptions: dividend yield per
share is nil, expected volatility of zero, risk-free interest rate range from 4.25% to
5.44%, expected life of 10 years. |
|
The
weighted fair value of options granted by the subsidiary during 2002 is $ 3.24. The
fair value of each option grant is estimated on the date of grant using the Black-Scholes
option-pricing model with the following weighted average assumptions: dividend yield per
share is nil, expected volatility of zero, risk-free interest rate range from 5.29% to
5.44%, expected life of 10 years. |
|
The
weighted fair value of options granted by the subsidiary during 2001 is $ 3.25. The
fair value of each option grant is estimated on the date of grant using the Black-Scholes
option-pricing model with the following weighted average assumptions: dividend yield per
share is nil, expected volatility of zero, risk-free interest rate of 5.29 %, expected
life of 10 years. |
|
As
of December 31, 2003, 607,750 options were exercisable. |
|
At
December 31, 2003, had all options been exercised, the Companys share in the equity
of the US subsidiary would have decreased from 100 % to approximately 93 %. Subsequent to
December 31, 2003, the Company sold the operations of the US subsidiary and all options
under the US Subsidiary Plan were cancelled. See also note 1b. |
|
Dividends
are declared and paid in dollars (except to shareholders of record with an address in
Israel, with respect to whom payment is made in Israeli currency (NIS)). |
NOTE 12 TAXES ON
INCOME:
|
a. |
The
Company and its Israeli subsidiary: |
|
1) |
Tax
benefits under the Israeli Law for the Encouragement of Capital Investments,
1959 (hereafter- the law) |
|
By
virtue of the approved enterprise status granted to certain production
facilities under the law, the Israeli subsidiary is entitled to various tax benefits, as
follows: |
|
The
tax benefit period is seven years from the year in which the approved enterprise first
earns taxable income. Income derived from the approved enterprise is tax exempt during
the first two years of the seven year tax benefit period and is subject to a reduced tax
rate of 25 % during the remaining five years of benefits. The period of benefits relating
to the approved enterprise will expire in the years 2009-2010. |
34
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 12 TAXES ON INCOME
(continued):
|
In
the event of distribution of cash dividends out of income which was tax exempt as above,
the Israeli subsidiary would have to pay the 25 % tax in respect of the amount
distributed. |
|
The
Israeli subsidiary intends to permanently reinvest the amounts of tax-exempt income in
the foreseeable future, and not to cause distribution of such dividends. |
|
b) |
Accelerated
depreciation |
|
The
Israeli subsidiary is entitled to claim accelerated depreciation for five tax years
commencing in the first year of operation of each asset, in respect of machinery and
equipment used by the approved enterprise. |
|
c) |
Conditions
for entitlement to the benefits |
|
The
entitlement to the above benefits is conditional upon the Israeli subsidiarys
fulfilling the conditions stipulated by the law, regulations published hereunder and the
instruments of approval for the specific investments in the approved enterprise.
In the event of failure to comply with these conditions, the benefits may be cancelled
and the Israeli subsidiary may be required to refund the amount of the benefits, in whole
or in part, with the addition of linkage differences to the Israeli consumer price index (CPI)
and interest. |
|
2) |
Measurement
of results for tax purposes under the Income Tax (Inflationary Adjustments)
Law, 1985 (hereafter the Inflationary Adjustments Law) |
|
Under
this law, results for tax purposes are measured in real terms, in accordance with the
changes in the Israeli CPI, or in the exchange rate of the dollar for a foreign
investors company. The Company and its Israeli subsidiaries elected to
measure their results on the basis of the changes in the Israeli CPI. |
|
Paragraph
9 (f) of FAS 109, Accounting for Income Taxes, prohibits the recognition of
deferred tax liabilities or assets that arise from differences between the financial
reporting and tax bases of assets and liabilities that are measured from the local
currency into dollars using historical exchange rates, and that result from changes in
exchange rates or indexing for tax purposes. Consequently, the abovementioned differences
were not reflected in the computation of deferred tax assets and liabilities. |
|
3) |
Tax
benefits under the Law for the Encouragement of Industry (Taxation), 1969 |
|
The
Israeli subsidiary is an industrial company as defined by this law and as
such is entitled to certain tax benefits, mainly accelerated depreciation of machinery
and equipment, as prescribed by regulations published under the Inflationary Adjustments
Law, and the right to claim public issuance expenses and amortization of patents and
other intangible property rights as a deduction for tax purposes. |
|
4) |
Tax
rates applicable in Israel to income not derived from an approved enterprise |
|
Income
not eligible for the approved enterprise benefits mentioned in (1) above is
taxed at the regular rate of 36 %. |
35
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 12 TAXES ON INCOME
(continued):
|
b. |
Non-Israeli
subsidiaries |
|
The
non-Israeli subsidiaries are taxed under the laws of their countries of residence. |
|
c. |
Carryforward
tax losses and deductions |
|
Carryforward
tax losses and deductions of the Company and its subsidiaries, including capital losses
and losses from realization of marketable securities approximated $ 500 million at
December 31, 2003. Most of the carryforward amounts are available indefinitely with
no expiration date. |
|
d. |
Reform
of the Israeli tax system |
|
In
2002, Amendment to the Israeli Tax ordinance (No. 132), 2002 (the Israeli Tax
Reform Law) was published. The Israeli Tax reform Law comprehensively reforms
certain parts of the Israeli tax system and entered into effect on January 1, 2003,
although certain provisions thereof will be applied from later dates.
The
Israeli subsidiaries expects that the implementation of the Israeli tax reform will not
have a material effect on its tax status and liabilities thereof. |
|
e. |
Deferred
income taxes: |
|
December 31
|
|
2003
|
2002
|
|
$ in thousands
|
|
|
|
Computed in respect of the following: |
|
|
| |
|
| |
|
Allowance for doubtful accounts and | | |
other provisions | | |
| 1,512 |
|
| 1,188 |
|
Carryforward tax losses and credits | | |
| 168,620 |
|
| 99,076 |
|
Inventories | | |
| 1,440 |
|
| 540 |
|
Investments | | |
| 9,364 |
|
| 23,245 |
|
Accrued liabilities and deferred income | | |
| 1,173 |
|
| 406 |
|
Property, plant and equipment | | |
| 60 |
|
| 64 |
|
Intangible assets | | |
| 2,927 |
|
| 600 |
|
|
| |
| |
| | |
| 185,096 |
|
| 125,119 |
|
L e s s - valuation allowance (attributed | | |
mainly to loss carryforwards and expenses | | |
deductible upon payment) | | |
| (184,984 |
) |
| (123,253 |
) |
|
| |
| |
| | |
| 112 |
|
| 1,866 |
|
|
| |
| |
Deferred income taxes are included in the | | |
balance sheets as follows: | | |
Non-current assets | | |
| 112 |
|
| 1,866 |
|
|
| |
| |
36
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 12 TAXES ON INCOME
(continued):
f.
Loss before taxes on income from continuing operation:
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
$ in thousands
|
|
|
|
|
The Company and its Israeli subsidiaries |
|
|
| (23,616 |
) |
| (29,198 |
) |
| (187,906 |
) |
Non-Israeli subsidiaries | | |
| 9,453 |
|
| (3,868 |
) |
| (1,632 |
) |
|
| |
| |
| |
| | |
| (14,163 |
) |
| (33,066 |
) |
| (189,538 |
) |
|
| |
| |
| |
|
g. |
Taxes
on income included in the statements of operations from continuing
operation: |
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
$ in thousands
|
|
|
|
|
Current: |
|
|
| |
|
| |
|
| |
|
Israeli | | |
| (404 |
) |
| 400 |
|
| 3,547 |
|
Non-Israeli | | |
| 1,052 |
|
| (984 |
) |
| 1,212 |
|
|
| |
| |
| |
| | |
| 648 |
|
| (584 |
) |
| 4,759 |
|
|
| |
| |
| |
Deferred, see e. above: | | |
Israeli | | |
| 1,866 |
|
| (64 |
) |
| (1,802 |
) |
Non-Israeli | | |
| (112 |
) |
|
| |
| |
| |
| | |
| 1,754 |
|
| (64 |
) |
| (1,802 |
) |
|
| |
| |
| |
| | |
| 2,402 |
|
| (648 |
) |
| 2,957 |
|
|
| |
| |
| |
37
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 12 TAXES ON INCOME
(continued):
|
2) |
Following
is a reconciliation of the theoretical tax expense, assuming all income is
taxed at the regular tax rate applicable to Israeli corporations (see a(4)
above) and the actual tax expense: |
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
$ in thousands
|
|
|
|
|
Income (loss) before taxes on income |
|
|
| (14,163 |
) |
| (33,066 |
) |
| (189,538 |
) |
|
| |
| |
| |
Theoretical tax expense (tax benefit) on | | |
the above amount | | |
| (5,099 |
) |
| (11,904 |
) |
| (68,234 |
) |
Effect of lower tax rate for | | |
"approved enterprises" | | |
| |
|
| (400 |
) |
|
| |
| |
| |
| | |
| (5,099 |
) |
| (12,304 |
) |
| (68,234 |
) |
Increase (decrease) in taxes resulting from | | |
different tax rates - net | | |
| (6,670 |
) |
| (5,253 |
) |
| 130 |
|
Increase in taxes resulting from | | |
permanent differences | | |
| 838 |
|
| 408 |
|
| 666 |
|
Change in valuation allowance | | |
| 61,731 |
|
| 87,602 |
|
| 76,849 |
|
Changes in deferred taxes resulting from | | |
carryforward tax losses | | |
| (49,970 |
) |
| (71,275 |
) |
| (4,246 |
) |
Increase in taxes resulting from prior years | | |
| 1,950 |
|
Increase (decrease) in taxes arising | | |
from differences between non-dollar | | |
currencies income and dollar | | |
income - net, and other* | | |
| (378 |
) |
| 174 |
|
| (2,208 |
) |
|
| |
| |
| |
Taxes on income in the consolidated | | |
statements of operations | | |
| 2,402 |
|
| (648 |
) |
| 2,957 |
|
|
| |
| |
| |
|
* |
Resulting
mainly from the difference between the changes in the Israeli CPI (the basis for
computation of taxable income of the Company and its Israeli subsidiaries, see a(2)
above) and the changes in the exchange rate of Israeli currency relative to the dollar. |
|
1) |
The
Company has received, or is considered to have receive, final tax assessments
through the 1998 tax year. |
|
2) |
In
partial settlement of an audit of the Internal Revenue Service (IRS) of the
Companys U.S. subsidiaries for the years 1992 through 1996, the
Company consented to a partial assessment by the IRS for
approximately $ 10.6 million of federal taxes on certain agreed upon
issues. This amount excludes interest and state income taxes, which will
be assessed by the IRS and are expected to almost double the above amount.
The Company has already made advance payments of $ 21.5 million on account
of this audit. In June 2002, the Company received a notice from the IRS
proposing to assess $ 29.6 million of additional federal income taxes for
the years 1992 through 1996. This amount excludes state income taxes and
interest, which would almost double that figure. In August 2002, the
Company appealed the proposed additional assessment. The Company has
conducted advanced negotiations with the IRS for settlement of this
assessment, which was finalized during February 2004 (see note 16a). The
Companys management believes, based on its consultants advice,
that sufficient provision for this matter is included in accrued
liabilities. |
38
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 12 TAXES ON INCOME
(continued):
|
3) |
During
2002, a couple of the Companys subsidiaries received tax assessments
for which the Companys management believes, based on its consultants advice,
sufficient provision was accrued. During 2003, one of those subsidiaries
consented to an assessment by the Israeli authorities for the years
1996-2001 for approximately $ 2.1 million, of which approximately $ 1.8
million will be payable in 24 monthly installments commencing April 2004.
This assessment was finally signed and settled in January 2004. Sufficient
provision was previously accrued in connection with the assessment. |
NOTE 13 FINANCIAL
INSTRUMENTS AND RISK MANAGEMENT:
|
a. |
Foreign
exchange risk management |
|
The
Company and its subsidiaries operate internationally, which gives rise to significant
exposure to market risks, mainly from changes in foreign exchange rates. Derivative
financial instruments (hereafter derivatives) were utilized by a subsidiary to
reduce these risks. The Company did not hold or issue derivative financial instruments
for trading purposes. |
|
Commencing
2003, a subsidiary purchases forward-exchange contracts as hedges of certain anticipated
sales and related costs denominated in foreign currencies. The subsidiary enters into
these contracts to protect itself against the risk that the eventual dollar-net-cash
inflows resulting from direct-foreign-export sales and related costs will be adversely
affected by changes in exchange rates. These contarcts are not qualified for hedge
accounting under FAS 133. Accordingly gains and losses for these forward-exchange
contracts are recognized in earnings.
As of December 31, 2003 the provision for losses
deriving from forward-exchange contracts amounted to approximately $ 556,000 and is
classified as accrued liability. |
|
b. |
Concentrations
of credit risks |
|
At
December 31, 2003 and 2002, the Company and its subsidiaries held cash and cash
equivalents, most of which were deposited with major Israeli, European and U.S. banks.
Substantially, all of the marketable securities held by the Company are debt securities
of the U.S. Treasury and highly rated corporations. The Company considers the inherent
credit risks to be remote. |
|
Most
of the subsidiaries sales are made in the United States, Latin America, Europe and
in the Far East, to a large number of customers. Consequently, the exposure to
concentrations of credit risks relating to individual customer receivables is limited.
The subsidiary performs ongoing credit evaluations of its customers and generally does
not require collateral; however, with respect of certain sales to customers in emerging
economies, the subsidiary requires letters of credit. The accounts include sufficient
allowance for doubtful accounts. |
39
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 13 FINANCIAL
INSTRUMENTS AND RISK MANAGEMENT (continued):
|
c. |
Fair
value of financial instruments |
|
The
financial instruments of the Company and its subsidiaries consist mainly of cash and cash
equivalents, short-term investments, long-term investments, current and long-term
liabilities. |
|
In
view of their nature, the fair value of the financial instruments included in working
capital is usually identical or close to their carrying amount. The fair value of
long-term liabilities also approximates their carrying value, since they bear interest at
rates close to the prevailing market rates. |
NOTE 14
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION:
|
December 31
|
|
2003
|
2002
|
|
$ in thousands
|
|
|
|
a. Allowance for doubtful accounts (as included |
|
|
| |
|
| |
|
in trade receivables) - the change in allowance | | |
for doubtful is composed as follows: | | |
Balance at beginning of year | | |
| 2,957 |
|
| 1,620 |
|
Addition to allowance | | |
| 1,233 |
|
| 1,507 |
|
Write-off of bad debts | | |
| |
|
| (170 |
) |
|
| |
| |
| | |
| 4,190 |
|
| 2,957 |
|
|
| |
| |
b. Inventories: | | |
Components of systems and materials | | |
| 5,413 |
|
| 3,391 |
|
Work in process | | |
| 1,183 |
|
| 1,517 |
|
Finished products | | |
| 15,979 |
|
| 15,152 |
|
|
| |
| |
| | |
| 22,575 |
|
| 20,060 |
|
|
| |
| |
c. Accrued and other liabilities: | | |
Payroll and related expenses | | |
| 3,863 |
|
| 2,875 |
|
Accrued royalties and sales commissions | | |
| 2,514 |
|
| 1,216 |
|
Deferred revenue | | |
| 5,308 |
|
| 3,853 |
|
Provision for warranty* | | |
| 2,293 |
|
| 2,018 |
|
Advances from customers | | |
| 2,516 |
|
| 1,163 |
|
Other | | |
| 9,183 |
|
| 5,826 |
|
|
| |
| |
| | |
| 25,677 |
|
| 16,951 |
|
|
| |
| |
* The changes in the balance during the year: | | |
Balance at beginning of the year | | |
| 2,018 |
|
| 2,577 |
|
Payments made under the warranty | | |
| (3,383 |
) |
| (3,136 |
) |
Product warranties issued for new sales | | |
| 3,658 |
|
| 3,589 |
|
Changes in accrual in respect of | | |
pre-existing warranties | | |
| |
|
| (1,012 |
) |
|
| |
| |
Balance at end of year | | |
| 2,293 |
|
| 2,018 |
|
|
| |
| |
40
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 14 SUPPLEMENTARY
FINANCIAL STATEMENT INFORMATION (continued):
|
d. |
Short-term
credit and long-term loans: |
|
In
2003 a subsidiary of the Company signed agreements with banks, which provided for a $ 49
million revolving line of credit, short-term and long-term loans for various purposes. |
|
Borrowings
under the revolving line of credit and long-term loans bore interest of Libor + 1.1 % to
Libor + 2.3 %. |
|
The
revolving line of credit the short-term and the long-term loans are secured by a negative
pledge and restricted deposits of $ 18,262,000 and require the subsidiary to maintain
certain financial and other restrictive covenants. |
|
The
subsidiary is currently not in full compliance with one of the restrictive covenants and
it is engaged in ongoing discussions with the banks for a temporary waiver of such
covenant. |
|
2) |
Short-term
credit and loans |
|
The
balance as of December 31, 2003, mainly represents short term credit and loans of Scitex
Vision, consisting of: $ 26,450,000 short-term bank loans denominated in dollars and
bearing interest of three month Libor + 1.1% to Libor + 2.25% per annum (as of December
31, 2003 2.3% to 3.5%, respectively); $ 14,689,000 short-term bank loans
denominated in Euro and bearing interest of one month Libor + 1.75 % to Libor + 2.3 % per
annum (as of December 31, 2002 3.8 % to 4.4 %, respectively) and $ 712,000 credit
lines in various currencies. The short-term bank loan denominated in dollar and bearing
interest of Libor +0.5 % per annum in the amount of $ 3,500,000 relates to SDC. |
|
3) |
Current
maturities of long-term loans (represent loans of Scitex Vision): |
|
2003
|
2002
|
|
$ in thousands
|
|
|
|
|
|
|
Banks |
|
|
| 1,633 |
|
| 5,248 |
|
Other | | |
| 969 |
|
|
| |
| |
| | |
| 2,602 |
|
| 5,248 |
|
|
| |
| |
|
a) |
The
long-term loans from banks represent loans of Scitex Vision and mature in
the following years subsequent to December 31, 2003: |
|
2003
|
2002
|
|
$ in thousands
|
|
|
|
|
|
|
Second year |
|
|
| 1,928 |
|
| 3,438 |
|
Third year | | |
| 1,252 |
|
| 2,003 |
|
Fourth year | | |
| 1,252 |
|
| 52 |
|
Fifth year and thereafter | | |
| 2,191 |
|
|
| |
| |
| | |
| 6,623 |
|
| 5,493 |
|
|
| |
| |
41
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 14 SUPPLEMENTARY
FINANCIAL STATEMENT INFORMATION (continued):
|
b) |
The
long-term loans from banks are denominated in dollars, bear interest of
three month Libor + 1.75 % to Libor + 2.25 % per annum (as of December 31,
2003 2.9 % to 3.4 %, respectively). |
|
c) |
In
2000, ScitexVision entered into a collaboration agreement (hereafter the
agreement) with a European leading supplier (hereafter the supplier)
to the textile, paper and plastic printing industry, for developing inks
for printing on textile. Pursuant to the agreement, the supplier shall pay
ScitexVision certain royalties on sales of ink for use with ScitexVisions
textile printing machines. As of December 31, 2003, no such sales have
been made. |
|
Following
the agreement, Scitex Vision received from the supplier a long-term convertible loan of $
5 million. |
|
The
loan received on December 27, 2000, and bore 6% annual interest. The loan should have
been interest free if the milestones described in the agreement were met. |
|
According
to the original terms of the loan, the loan and the accumulated interest might have been
converted by the supplier, at any time during the last three months of the loan period,
which ended on December 11, 2003, into ordinary shares of Scitex Vision at a conversion
price based on the fair value of such shares, less 15%. According to the agreement if the
supplier chooses to request the repayment of the loan, the repayment shall be made by
setting-off the loan and any interest accrued thereon against royalties due to Scitex
Vision in a subsequent period. The remainder of the loan, if it exists, shall be repaid
in cash to the supplier. |
|
On
December 30, 2003 an addendum to the agreement was signed, according to which, the
original terms of the loan were changed such that the principal of the loan is interest
free and payable in four annual installments in the following years subsequent to
December 31, 2003: |
|
December 31
|
|
2003
|
|
U.S. dollars in thousands
|
|
|
Current maturities |
|
|
| 969 |
|
|
| |
Second year | | |
| 1,171 |
|
Third year | | |
| 1,358 |
|
Fourth year | | |
| 1,094 |
|
|
| |
| | |
| 3,623 |
|
|
| |
| | |
| 4,592 |
|
|
| |
|
Scitex
Vision has the right to offset royalties due to Scitex Vision against the amount due, on
the next agreed installment. |
|
As
a result of the above-mentioned change in terms, the company has recorded the loan based
on its present value ($ 4,592,000) using the interest rate, which is applicable to such
loans as of the date of change in terms. The difference between thepresent value
and the nominal value of the loan, in the total amount of $ 408,000, as well as all
interest accrued through December 30, 2003, in the total amount of $ 904,000, were
credited to financial expenses net. |
42
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 14
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (continued):
|
5) |
Convertible
long-term loans from related parties: |
|
In
July 2003, two of the Companys shareholders granted to the Companys
subsidiary convertible loans in the amount of approximately $ 933,000, bearing interest
equal to the greater of Libor + 1% (as of December 31, 2003 2.1%) or rate of
change of the Israeli CPI per annum. The loans are payable in one installment at the end
of a five year period if no conversion occurs before the end of the repayment period. |
|
The
loans and the accumulated interest may be converted into the ordinary shares of the
subsidiary at any time with an exercise price of $ 0.4052 per share, which equals the
fair value of the subsidiarys ordinary shares at the date of grant of the loans. |
|
According
to the loans agreements, an automatic conversion shall occur upon certain events. In
addition, the lenders were granted with warrants representing 25% of the loan amount, to
purchase ordinary shares at an exercise price of $ 0.4052 per share. |
|
The
Company recorded an original discount of $ 98,500 in respect of the amounts allocated to
these warrants out of the total above-mentioned loans of $ 933,000. This amount is
amortized to the interest expense over the maximum term of the loans, which is 5 years. |
|
Pursuant
to the conversion terms, whereby the lenders were guaranteed beneficial conversion
features, the Company recorded an original discount of $ 98,500, which represents the
difference between the loan allocated amount and the amount payable. This amount is
amortized to the interest expense over the maximum term of the loans, which is 5 years. |
|
e. |
Note
payable issued to an investee company |
|
The
note was denominated in dollars and was repaid in one payment on April 4, 2003. |
43
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 14 SUPPLEMENTARY
FINANCIAL STATEMENT INFORMATION (continued):
|
Statements
of operations: |
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
$ in thousands
|
|
|
|
|
f. Research and development costs - net: |
|
|
| |
|
| |
|
| |
|
Expenses incurred | | |
| 11,537 |
|
| 7,761 |
|
| 7,082 |
|
L e s s - royalty-bearing | | |
participations from the | | |
Government of Israel | | |
| 467 |
|
| 701 |
|
| 999 |
|
|
| |
| |
| |
| | |
| 11,070 |
|
| 7,060 |
|
| 6,083 |
|
|
| |
| |
| |
g. Selling, general and administrative | | |
expenses: | | |
Selling* | | |
| 20,192 |
|
| 19,812 |
|
| 21,277 |
|
General and administrative** | | |
| 15,147 |
|
| 13,581 |
|
| 16,376 |
|
|
| |
| |
| |
| | |
| 35,339 |
|
| 33,393 |
|
| 37,653 |
|
|
| |
| |
| |
* Including: | | |
Advertising costs | | |
| 609 |
|
| 420 |
|
| 410 |
|
|
| |
| |
| |
** Including: | | |
Related party | | |
| 518 |
|
| 445 |
|
| 92 |
|
|
| |
| |
| |
Net change in allowance for | | |
doubtful accounts and direct | | |
write-off of bad debts | | |
| 698 |
|
| 1,507 |
|
| 1,082 |
|
|
| |
| |
| |
|
1. |
Towards
the end of 2001, a subsidiary implemented a restructuring plan, which was
completed in 2001, in the form of abandonment of construction in progress,
and accrued expenses accordingly. The expenses included the write-off of
fixed assets in the amount of approximately $ 500,000. |
|
2. |
During
2003, a subsidiary implemented a restructuring plan in the form of
reduction in work force, abandonment of leased premises and development of
new combined information technology system, and accrued expenses
accordingly. The expenses included mainly severance pay and other benefits
to approximately 42 employees retiring from their employ in the amount of
approximately $ 130,000, costs related to the disposal of certain
activities in the amount of approximately $ 390,000, and costs related to
the development of new combined information technology system in the
amount of approximately $ 500,000. |
44
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 14 SUPPLEMENTARY
FINANCIAL STATEMENT INFORMATION (continued):
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
$ in thousands
|
|
|
|
|
i. Financial expenses - net: |
|
|
| |
|
| |
|
| |
|
Interest income | | |
| 249 |
|
| 706 |
|
| 713 |
|
Gain on trading marketable securities - net | | |
| 3 |
|
| |
|
| 136 |
|
Interest expense on long-term loans | | |
from banks | | |
| (1,981 |
) |
| (2,471 |
) |
| (2,382 |
) |
from related parties | | |
| (20 |
) |
from others | | |
| 603 |
|
Bank charges | | |
| (276 |
) |
| (15 |
) |
| (127 |
) |
Revaluation of long-term loan | | |
| 408 |
|
Other (including foreign exchange | | |
transaction losses - net) | | |
| (1,637 |
) |
| (1,359 |
) |
| (1,268 |
) |
|
| |
| |
| |
| | |
| (2,651 |
) |
| (3,139 |
) |
| (2,928 |
) |
|
| |
| |
| |
j. Other income (loss) - net: | | |
Loss from change in percentage of | | |
holding of an associated company | | |
| |
|
| |
|
| (4,408 |
) |
Write-down of available-for-sale securities | | |
| |
|
| (22,283 |
) |
Gain from sale of a portion in a subsidiary | | |
| 3,774 |
|
Share in beneficial conversion feature of | | |
convertible preferred shares issued by a | | |
subsidiary | | |
| (3,485 |
) |
Write-off and write-down of investments | | |
in investee companies | | |
| (2,493 |
) |
| (3,839 |
) |
| (5,477 |
) |
Gain (loss) from sale of investments in | | |
associated and investee companies | | |
| 2,822 |
|
| |
|
| (6,041 |
) |
Other | | |
| 169 |
|
| (148 |
) |
| 2,892 |
|
|
| |
| |
| |
| | |
| 787 |
|
| (26,270 |
) |
| (13,034 |
) |
|
| |
| |
| |
|
k. |
Earnings
income (loss) per share: |
|
The
net loss and the weighted average number of shares used in computation of basic and
diluted earnings per share for the years ended December 31, 2003, 2002 and 2001 are as
follows: |
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
$ in thousands
|
|
|
|
|
Net income (loss) used in the computation |
|
|
| |
|
| |
|
| |
|
of basic and diluted | | |
earnings per share | | |
| 1,387 |
|
| (32,030 |
) |
| (253,020 |
) |
|
| |
| |
| |
Weighted average number of | | |
shares used in the computation of | | |
basic earnings (loss) per share | | |
| 43,018 |
|
| 43,018 |
|
| 43,018 |
|
Add - net additional shares from the | | |
assumed exercise of the Company's | | |
stock options | | |
| -,- |
|
| -,- |
|
| -,- |
|
|
| |
| |
| |
Weighted average number of | | |
shares used in the computation of | | |
diluted earnings (loss) per share | | |
| 43,018 |
|
| 43,018 |
|
| 43,018 |
|
|
| |
| |
| |
45
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 15 SEGMENT
INFORMATION:
|
Prior
to the sale of SDPs operations, as described in note 1b, the Company had been
operating in two reportable segments. Following the transaction the Company operates only
in the wide-format digital printing. The Subsidiaries, develop, manufacture and market
industrial digital inkjet printing solutions mainly to the graphic arts, packaging
and textile markets as well as related services and consumable products. As to the sale
of the high-speed digital printing segment, classified as discontinued operation, see
note 1b. In addition, the Company holds interest in other companies that develop digital
printing solution to industrial applications. |
|
b. |
Geographical
information: |
|
1) |
Following
are data regarding revenues from external customers in respect of continuing
operations, classified by geographical area based on the location of the
customers: |
|
Year ended December 31
|
|
2003
|
2002
|
2001
|
|
$ in thousands
|
|
|
|
|
North America (mostly USA) |
|
|
| 19,650 |
|
| 17,814 |
|
| 18,690 |
|
Mexico | | |
| 15,178 |
|
| 8,725 |
|
| 1,221 |
|
Europe: | | |
West | | |
| 25,313 |
|
| 24,524 |
|
| 29,339 |
|
East | | |
| 11,580 |
|
| 12,980 |
|
| 6,846 |
|
Far East | | |
| 12,460 |
|
| 16,647 |
|
| 29,860 |
|
Other countries | | |
| 18,699 |
|
| 4,971 |
|
| 5,662 |
|
|
| |
| |
| |
| | |
| 102,880 |
|
| 85,661 |
|
| 91,618 |
|
|
| |
| |
| |
|
2) |
Following
are data relating to property, plant and equipment, net, relating to continuing
operations, by geographical area in which the assets are located: |
|
December 31
|
|
2003
|
2002
|
2001
|
|
$ in thousands
|
|
|
|
|
Israel |
|
|
| 6,154 |
|
| 2,985 |
|
| 2,772 |
|
North and South America | | |
| 802 |
|
| 1,033 |
|
| 1,919 |
|
Europe | | |
| 1,152 |
|
| 753 |
|
| 511 |
|
South Africa | | |
| 949 |
|
| 1,265 |
|
| 1,024 |
|
Asia | | |
| 147 |
|
| 38 |
|
|
| |
| |
| |
| | |
| 9,204 |
|
| 6,074 |
|
| 6,226 |
|
|
| |
| |
| |
46
SCITEX CORPORATION LTD.
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (continued)
NOTE 16
SUBSEQUENT EVENTS
|
a. |
In
January 2003, the Board of Directors of the Company announced a planned
distribution to shareholders of approximately $2.75 per share (a total of
approximately $118 million), applying a portion of the net proceeds from
the SDP sale. Distributions to shareholders will be subject to applicable
withholding taxes. The cash distribution to shareholders is subject to the
satisfaction of certain conditions, including the approval of Companys
shareholders and of the Israeli District Court. There can be no assurance
if and when such conditions will be satisfied. |
|
b. |
In
February 2004, the Company has entered into an agreement with the IRS to
resolve a U.S. federal income tax audit of its U.S. subsidiaries for the
years 1992 through 1996. Under the terms of the agreement, the Company
agreed to an assessment of $5.7 million of additional federal income taxes
for these years to resolve the remaining proposed IRS assessment of an
additional $29.6 million of federal income taxes (as described in note
12h(2)). |
|
When
added to a previous partial agreed assessment by the IRS for $10.6 million of
federal income taxes, the Companys total additional federal income taxes for these
years as a result of the IRS audit will be $16.3 million. This amount does not include
interest and additional state income taxes that will result from the agreement with the
IRS. The Company is currently working to determine such amounts. |
|
The
Company had previously made advance payments to the IRS of $21.5 million for federal
income taxes relating to the audit period and had established reserves for additional
liabilities arising out of the audit. At this stage, after initial review, the Company
estimates that the final additional cash cost of the IRS audit (taking into consideration
the $16.3 million of assessment, state taxes and interest thereon, and after application
of the $21.5 million advance payment), will be in the range of $7 to $14 million. |
|
The
Companys management believes, based on its consultants advice, that
sufficient provision for this matter is included in accrued liabilities. |
|
c. |
In
February 2004, the Company concluded a $1.5 million investment in Jemtex in
consideration for convertible debentures, which may be repaid at the
option of Jemtex until the end of June 2004. Out of the above amount,
$0.45 million were transferred to Jemtex on account of the investment (see
note 4a). Following this investment, the Company effectively holds
approximately 73% of Jemtex issued share capital on an as
converted basis. |
47
REPORT OF
INDEPENDENT AUDITORS
To the shareholders
of
JEMTEX INK JET PRINTING LTD.
We have audited the accompanying
balance sheet of Jemtex Ink Jet Printing Ltd. (the Company) as of
December 31, 2003 and the related statement of operations, changes in shareholders
deficiency and cash flow for the year then ended. These financial statements are the
responsibility of the Companys management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance
with auditing standards generally accepted in the United States. Those standards require
that we plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial statements.
An audit also includes assessing the accounting principles used and significant estimates
made by the companys management, as well as evaluating the overall financial
statement presentation. We believe that our audits and provide a reasonable basis for our
opinion.
In our opinion, the financial
statements referred to above present fairly, in all material respects, the financial
position of the Company as of December 31, 2003 and the results of its operation and its
cash flow for the year then ended, in conformity with accounting principles generally
accepted in the United States.
The accompanying financial statements
have been prepared assuming that the Company will continue as a going concern. As
discussed in Note 1B, to the financial statements, the Company has suffered recurring
losses from operations and as of December 31, 2003 has a shareholders deficiency of
approximately $ 1.9 million. These factors, among others described in Note 1B raise
substantial doubt about the Companys ability to continue as a going concern.
Managements plans in regard to these matters are also described in Note 1B. The
financial statements do not include any adjustments to reflect the possible future effects
on the cover ability and classification of assets or the amounts and classification of
liabilities that might result from the outcome of this uncertainty.
Tel-Aviv, Israel
February 29, 2004
|
|
/s/ Ziv Haft
ZIV HAFT
a member of BDO Certified Public Accountants (Isr.) |
48
|
Chaikin, Cohen, Rubin & Gilboa.
Atidim Technology Park, Bldg. 4,
P.O.B. 58143 Tel-Aviv 61580, Israel
Tel: 972-3-6489858 Fax: 972-3-6489946
E-mail: accounting@ccrcpa.co.il
|
|
Certified Public Accountants (Isr.)
|
REPORT OF INDEPENDENT
PUBLIC ACCOUNTANTS
To The Shareholders of
Objet Geometries Ltd.
We have audited the accompanying
consolidated balance sheets of Objet Geometries Ltd., (the Company) as of
December 31, 2003 and 2002 and the related consolidated statements of operations, changes
in shareholders equity and cash flows for each of the three years in the period
ended December 31, 2003. These financial statements are the responsibility of the
Companys management. Our responsibility is to express an opinion on the financial
statements based on our audit.
We conducted our audit in accordance
with auditing standards generally accepted in Israel, including those prescribed under the
Auditors Regulations (Auditors Mode of Performance), 1973. Those standards
require that we plan and perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatements. An audit includes examining,
on a test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management as well as evaluating the overall financial
statements presentation. We believe that our audits provide a reasonable basis for our
opinion.
In our opinion, the financial
statements referred to above present fairly, in all material respects, the consolidated
financial position of the Company as of December 31, 2003 and 2002 and the consolidated
results of its operations and its cash flows for each of the three years in the period
ended December 31, 2003, in conformity with accounting principles generally accepted in
the United States.
Without qualifying our opinion, we
wish to draw your attention to the following matters:
1. |
The
Companys capital deficiency as at December 31, 2003, and the loss for the
year then ended, amounting to approximately 4.0 million dollars and 6.2 million
dollars, respectively. The Companys continuation as a going concern is
dependent upon additional financial support until profitability is achieved.
The financial statements do not include any adjustments relating to
recoverability and classification of the assets and liabilities that might be
necessary should the company be unable to continue as a going concern. |
2. |
On
December 16, 2003 a lawsuit was filed against the Company See Note 10E. |
/s/ Chaikin, Cohen, Rubin & Gilboa
Chaikin, Cohen, Rubin & Gilboa
Certified Public Accountants (Isr.)
Tel-Aviv, February 16, 2004